Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Environ Int. 2015 Jul 24;84:39–54. doi: 10.1016/j.envint.2015.07.009

Prenatal and postnatal manganese teeth levels and neurodevelopment at 7, 9, and 10.5 years in the CHAMACOS cohort

Ana M Mora 1,2, Manish Arora 3, Kim G Harley 1, Katherine Kogut 1, Kimberly Parra 4, David Hernández-Bonilla 5, Robert B Gunier 1, Asa Bradman 1, Donald R Smith 6, Brenda Eskenazi 1,*
PMCID: PMC4570875  NIHMSID: NIHMS710521  PMID: 26209874

Abstract

Background

Numerous cross-sectional studies of school-age children have observed that exposure to manganese (Mn) adversely affects neurodevelopment. However, few prospective studies have looked at the effects of both prenatal and postnatal Mn exposure on child neurodevelopment.

Methods

We measured Mn levels in prenatal and early postnatal dentine of shed teeth and examined their association with behavior, cognition, memory, and motor functioning in 248 children aged 7, 9, and/or 10.5 years living near agricultural fields treated with Mn-containing fungicides in California. We used generalized linear models and generalized additive models to test for linear and nonlinear associations, and generalized estimating equation models to assess longitudinal effects.

Results

We observed that higher prenatal and early postnatal Mn levels in dentine of deciduous teeth were adversely associated with behavioral outcomes, namely internalizing, externalizing, and hyperactivity problems, in boys and girls at 7 and 10.5 years. In contrast, higher Mn levels in prenatal and postnatal dentine were associated with better memory abilities at ages 9 and 10.5, and better cognitive and motor outcomes at ages 7 and 10.5 years, among boys only. Higher prenatal dentine Mn levels were also associated with poorer visuospatial memory outcomes at 9 years and worse cognitive scores at 7 and 10.5 years in children with higher prenatal lead levels (≥0.8 μg/dL). All these associations were linear and were consistent with findings from longitudinal analyses.

Conclusions

We observed that higher prenatal and early postnatal Mn levels measured in dentine of deciduous teeth, a novel biomarker that provides reliable information on the developmental timing of exposures to Mn, were associated with poorer behavioral outcomes in school-age boys and girls and better motor function, memory, and/or cognitive abilities in school-age boys. Additional research is needed to understand the inconsistencies in the neurodevelopmental findings across studies and the degree to which differences may be associated with different Mn exposure pathways and biomarkers.

Keywords: manganese, teeth, neurodevelopment, children, California

1. Introduction1

Manganese (Mn) is an essential element involved in important enzymatic reactions (Aschner 2000; Gwiazda et al. 2002), but in excess, it is a potent neurotoxicant (Menezes-Filho et al. 2009a; Mergler and Baldwin 1997; Roels et al. 2012). Food is the main source of Mn for the general population (ATDSR 2012), but environmental exposure to Mn can occur from water naturally high in Mn or contaminated by industrial waste (Bouchard et al. 2007; Bouchard et al. 2011b; He et al. 1994; Kondakis et al. 1989), combustion of anti-knock additives in gasoline (Zayed et al. 1999), Mn mining operations (Riojas-Rodriguez et al. 2010), ferromanganese production facilities (Haynes et al. 2010; Menezes-Filho et al. 2009b), and spraying of Mn-containing fungicides (Gunier et al. 2013; Mora et al. 2014). Absorption and distribution of ingested Mn are closely regulated through homeostatic mechanisms (Papavasiliou et al. 1966; Roth 2006). However, inhaled Mn can directly enter the systemic circulation through the lungs (Vitarella et al. 2000) and access the brain directly through the olfactory bulb (Dorman et al. 2002; Elder et al. 2006; Leavens et al. 2007), bypassing biliary excretion mechanisms.

Children and infants may be particularly susceptible to the neurotoxic effects of Mn exposure as their Mn homeostatic mechanisms are poorly developed (Aschner 2000; Ljung and Vahter 2007; Yoon et al. 2009) and Mn can enter their developing brains by crossing the blood-brain barrier (Aschner 2000; Aschner and Dorman 2006). Multiple studies have reported associations between exposure to Mn and neurodevelopmental problems in children. Higher in utero Mn levels measured in blood and teeth have been associated with attention problems (Ericson et al. 2007; Takser et al. 2003), behavioral disinhibition (Ericson et al. 2007), impaired non-verbal memory (Takser et al. 2003), and poor cognitive and language development (Lin et al. 2013) in toddlers and preschoolers, and with externalizing behavior and attention problems (Ericson et al. 2007) in school-aged children. Postnatal Mn exposure has been associated with poor language development in toddler boys (Rink et al. 2014), and behavioral problems in school-aged boys and girls (Ericson et al. 2007). Studies of school-aged children and adolescents (6–14 year olds) have linked elevated Mn levels in drinking water, blood, and hair samples with oppositional behavior and hyperactivity (Bouchard et al. 2007), impaired cognitive abilities (Bouchard et al. 2011b; Kim et al. 2009; Menezes-Filho et al. 2011; Riojas-Rodriguez et al. 2010; Wasserman et al. 2006), and poor memory (He et al. 1994; Torres-Agustin et al. 2013), motor coordination (He et al. 1994; Hernandez-Bonilla et al. 2011; Lucchini et al. 2012), and visuoperceptive speed (He et al. 1994; Zhang et al. 1995). To date, only one epidemiologic study has assessed exposure to Mn both prenatally and postnatally (Ericson et al. 2007).

Blood Mn has typically been used as a biomarker of exposure to Mn in occupational and population-based studies of adults and children (Mergler et al. 1999; Takser et al. 2003), while studies in environmentally-exposed children have also measured Mn levels in hair (Bouchard et al. 2007; Bouchard et al. 2011b; Eastman et al. 2013; Menezes-Filho et al. 2011; Riojas-Rodriguez et al. 2010; Wright et al. 2006), in the exposure medium (e.g., water) (Bouchard et al. 2011b; Khan et al. 2012; Wasserman et al. 2006), or in teeth (Arora et al. 2012; Ericson et al. 2007). Studies on Mn toxicokinetics suggest that blood may best reflect recent exposures (i.e., days), while teeth may integrate longer-term exposures (e.g., months or longer) (Arora et al. 2011; Arora et al. 2012; Ericson et al. 2007; Smith et al. 2007). Deciduous teeth incorporate Mn in an incremental pattern and dentine, unlike enamel, can provide reliable information on the developmental timing of exposures to Mn that occur between the second trimester of pregnancy (starting at 13–16 weeks gestation, when incisors begin forming) and 10–11 months after birth (when molars stop developing) (Arora et al. 2012).

In this study, we measured prenatal and early postnatal dentine Mn levels in children’s deciduous teeth, and examined the association of Mn levels with behavior, cognition, memory, and motor development in 7-, 9-, and 10.5-year-old children living in an agricultural community in California where large amounts of Mn-containing fungicides are applied.

2. Methods

2.1. Study population

The Center for the Health Assessment of Mother and Children of Salinas (CHAMACOS) is a birth cohort study examining the health effects of pesticide and other environmental exposures in Mexican-American children living in the Salinas Valley, California. Common crops in this agricultural region include lettuce, strawberries, grapes, and broccoli. About 110,000 kg of Mn-containing fungicides, mancozeb and maneb (20% Mn by weight) (FAO 1980), were used in Monterey County in 2012 (CDPR 2014), but almost 160,000 kg were applied in 1999–2000, when study participants were pregnant (CDPR 2001).

Detailed methods for the CHAMACOS study have been described elsewhere (Eskenazi et al. 2004; Eskenazi et al. 2006). Briefly, eligible pregnant women (≥18 years old, <20 weeks of gestation, Spanish- or English-speaking, qualified for low-income health insurance, and planning to deliver at the county hospital) were recruited in community clinics between September 1999 and December 2000. Six hundred and one pregnant women were enrolled and 526 of them delivered live-born singletons (referred to henceforth as the CHAM1 cohort).

A second cohort of 300 9 year-olds (referred to henceforth as the CHAM2 cohort) was recruited between September 2009 and August 2011. CHAM2 children were born between February 2000 and August 2002 to approximately match the birth dates of CHAM1 children. Children were eligible to participate if their mother, when pregnant, was ≥18 years old, Spanish- or English-speaking, qualified for low-income health insurance, and received prenatal care at any low-income provider in the Salinas Valley.

Because CHAM2 enrollment began at age 9, only CHAM1 children completed the neurobehavioral test battery at age 7 (n = 339). CHAM1 and CHAM2 children completed identical neurobehavioral assessments at ages 9 (n = 634) and 10.5 (n = 615). Standardized assessments were conducted by bilingual psychometricians who were trained and supervised by a pediatric neuropsychologist. Subtests were administered in the dominant language of the child, which was determined through administration of the Oral Vocabulary subtest of the Woodcock-Johnson/Woodcock-Muñoz Tests of Cognitive Ability in both English and Spanish (Woodcock and Johnson 1990).

Teeth were collected for 282 CHAM1 and 173 CHAM2 children, but due to financial and logistical constraints, only teeth for 227 CHAM1 children and 70 CHAM2 children were analyzed. For this study, we excluded 39 children who provided a shed molar instead of an incisor, four children with a medical condition that would affect the neurobehavioral assessment (i.e., one with autism, and three with history of seizures), three children who were twins, and three children missing all neurobehavioral assessments. Children included in these analyses (n = 248) did not differ significantly from the full sample of CHAM1 (n = 335) and CHAM2 (n = 309) children on most attributes, including maternal marital status, poverty category at age 9, and child’s birth weight. However, children included in these analyses had older mothers (mean age = 26.8 vs. 25.6 years, p <0.01) with poorer cognitive abilities [mean maternal Peabody Picture Vocabulary Test (PPVT) score = 88.9 vs. 93.2 points, p <0.01] than the full sample of CHAM1 and CHAM2 children.

All study activities were approved by the University of California at Berkeley Committee for the Protection of Human Subjects, and written informed consent was obtained from all mothers. Child verbal assent was obtained at 7, 9, and 10.5 years of age.

2.2. Maternal interviews and assessments

CHAM1 mothers were interviewed twice during pregnancy (median, 13 and 26 weeks gestation), shortly after delivery, and when children were 6 months, and 1, 2, 3.5, 5, 7, 9, and 10.5 years old. CHAM2 mothers were interviewed when their children were 9 and 10.5 years old. Interviews were conducted in English or Spanish by trained bilingual interviewers. CHAM1 mothers were administered the Revised PPVT or Test de Vocabulario en Imágenes Peabody (TVIP) of Verbal Intelligence (Dunn and Dunn 1981) at the 6-month and 9-year visits; CHAM2 mothers completed the PPVT/TVIP at the 9-year visit only. CHAM1 mothers also completed the Center for Epidemiologic Studies Depression Scale (CES-D) (Radloff 1977) at the 7- and 9-year visits, and the Middle Childhood and Early Adolescence Home Observation for Measurement of the Environment (HOME) inventory short form (Caldwell and Bradley 1984) at the 7-, 9-, and 10.5-year visits, while CHAM2 mothers completed these scales only at the 9- and 10.5-year visits. Additional information, such as birth weight and gestational duration, was abstracted from prenatal and delivery medical records for both CHAM1 and CHAM2 participants. Data on maternal hemoglobin during pregnancy (median, 25 weeks gestation) were abstracted for CHAM1 children only.

2.3. Behavior

Mothers and teachers of CHAM1 children were administered either the English or Spanish version of the Parent and Teacher Rating Scales of the Behavior Assessment System for Children, 2nd edition (BASC-2) (Reynolds and Kamphaus 2004) and the Conners’ Attention Deficit Hyperactivity Disorder (ADHD)/Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) Scales (CADS) (Conners 2001) when children were 7 years old. CHAM1 and CHAM2 mothers were administered the CADS at the 9-year visit and the BASC-2 at the 10.5-year visit. Scores for four CADS subscales (Conners ADHD index, and DSM-IV-based Inattentive, Hyperactive/Impulsive, and Total ADHD), two BASC-2 subscales (Hyperactivity and Attention Problems), and two BASC-2 composite scales (Internalizing and Externalizing problems) were calculated and standardized to a nonclinical population (age-standardized T-scores, mean ± SD = 50 ± 10), with higher values indicating more frequent behavioral problems.

At 9 years of age, CHAM1 and CHAM2 children completed the Conners’ Continuous Performance Test II, Version 5 (CPT-II) (Conners 2002), a computerized test that assesses accuracy and impulse control. Scores for errors of commission (false positive) and errors of omission (false negative) were analyzed as continuous, sex- and age-standardized T-scores (mean ± SD = 50 ± 10). A continuous ADHD Confidence Index score, indicating the probability of children being correctly classified as having clinical ADHD, was also examined.

At the 10.5-year visit, CHAM1 and CHAM2 children were administered the BASC-2 Self-Report of Personality, Child Version (Reynolds and Kamphaus 2004). Scores for two subscales (Hyperactivity and Attention problems) were compared to national norms to generate age-standardized T-scores (mean ± SD = 50 ± 10), with higher scores indicating more frequent behavioral problems.

2.4. Cognition

CHAM1 children were administered either the English or Spanish version of the Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) (Wechsler 2003) at the 7-year study visit. At 10.5 years of age CHAM1 and CHAM2 children were also administered the WISC-IV. Scores for four domains were calculated at both time points: Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed. A Full-Scale intelligence quotient (IQ) was also calculated. WISC-IV scores were standardized against U.S. population-based norms for English- and Spanish-speaking children and analyzed as continuous variables.

2.5. Visuospatial and verbal memory

At the 9-year visit, CHAM1 and CHAM2 children completed a test of visuospatial memory, the NEPSY-II Memory for Designs (Korkman et al. 2007). We calculated continuous scaled scores (mean ± SD = 10 ± 3) for immediate and delayed memory using normative values for the corresponding chronological age.

At age 10.5 years, children’s verbal learning and memory abilities were assessed using either the English or Spanish version of the Children’s Auditory Verbal Learning Test, 2nd edition (CAVLT-2) (Talley 1997; Torres-Agustin et al. 2013). We analyzed four subscales as continuous standardized scores (mean ± SD = 100 ± 15): Learning curve (learning progression), Immediate recall (susceptibility of new information to be disrupted), Delayed recall (long-term memory and retrieval ability), Immediate memory span (short-term memory), and Level of learning (long-term memory coding abilities) (Torres-Agustin et al. 2013).

2.6. Motor functioning

CHAM1 children were administered finger-tapping (Reitan Neuropsychology Laboratory, Tucson, AZ) and pegboard (Wide Range Assessment of Visual Motor Ability, WRAVMA) (Adams and Sheslow 1995) tests at age 7 to assess fine motor dexterity. Finger-tap scores were standardized within our study population (z-scores, mean ± SD = 0 ± 1), but pegboard scores were age-standardized to a mean of 100 (SD = 15).

At ages 9 and 10.5 years, CHAM1 and CHAM2 children were administered parts of the Luria Nebraska Motor Battery (Golden et al. 1980). We selected for analysis seven subtests that have shown sensitivity to Mn exposure (Lucchini et al. 2012): dominant hand clench, non-dominant hand clench, alternative hand clench, finger-thumb touching with dominant hand, finger-thumb touching with non-dominant hand, alternative hand tapping twice with dominant hand and once with non-dominant hand, and alternative hand tapping twice with non-dominant hand and once with dominant hand. The sum of the scores of the five subtests administered by Lucchini et al. (2012) and the sum of all seven subtests were standardized within our study population (z-scores, mean ± SD = 0 ± 1).

2.7. Tooth Mn measurements

Tooth collection started at the 7-year visit for CHAM1 children and at the 9-year visit for the CHAM2 children. Participants were asked to mail or bring to the study visits the child’s shed teeth. Detailed methods for measuring Mn in teeth dentine and its validation as a biomarker of prenatal and early postnatal Mn exposure have been described elsewhere (Arora et al. 2011; Arora et al. 2012). Briefly, incisors were sectioned in a vertical plane, cleaned in an ultrasonic bath of Milli-Q water, and dried in an oven at 60°C for 24 h. Then the neonatal line, a histological feature used to demarcate prenatally and postnatally formed regions of enamel and dentine (Sabel et al. 2008), was identified using light microscopy. Mn levels and spatial distribution in prenatal and postnatal mantle dentine were determined with laser ablation-inductively coupled plasma-mass spectrometry using the neonatal line as a reference. Because multiple measurements were taken in prenatal and postnatal dentine, we calculated the area under the curve (AUC) to estimate cumulative Mn exposure in prenatal (from 13–16 weeks gestation to birth) and postnatal (from birth to approximately 2.5 months of age) periods. Mn levels were normalized to 43Ca to adjust for variations in mineralization. Coefficients of variation for five teeth measured on three different days ranged from 4.5% to 9.5% indicating good reproducibility of 55Mn:43Ca dentine measurements. Mn levels below the limit of detection (LOD = 0.001 55Mn:43Ca AUC × 104) were set at LOD/√2 (n = 4 postnatal dentine samples). In addition, four children had Mn measurements in prenatal dentine but no measurements in postnatal dentine due to tooth wear.

2.8. Other environmental toxicants

We examined the potential confounding or effect modification of known or suspected neurotoxicants, including organophosphorous (OP) pesticides, lead, and polybrominated diphenyl ether flame retardants (PBDEs), in CHAM1 children. Prenatal exposure to OP pesticides, indicated by urinary dialkyl phosphate (DAP) metabolite levels, was measured in maternal urine samples collected at approximately 13 and 26 weeks of gestation using an isotope dilution gas chromatography-tandem mass spectrometry method (Bradman et al. 2005). Blood lead levels were quantified in cord blood, maternal samples collected at about 26 weeks of gestation, or maternal samples collected at delivery (n = 59, 53, and 53, respectively) using graphite furnace atomic absorption spectrometry. Lead was also quantified in blood samples collected from children at 12 (n = 161) and 24 months (n = 176). PBDEs were measured in maternal blood samples at approximately 26 weeks of gestation using high-resolution gas chromatography/high-resolution mass spectrometry with isotope dilution quantification (Sjodin et al. 2004). PBDE levels were expressed on a serum lipid basis. Total lipids were quantified by measuring triglycerides and total cholesterol in serum (Phillips et al. 1989).

2.9. Data analysis

Prenatal and postnatal dentine Mn levels were transformed to the log2 scale to normalize the residuals and reduce the influence of outliers. We examined the association between teeth Mn levels and neurodevelopment using multivariable linear regression models. We also examined potential non-linear associations using generalized additive models with a three-degrees-of-freedom cubic spline function. If a potentially nonlinear association between dentine Mn levels and any of the neurodevelopmental outcomes was identified (pGAM <0.05), we created indicator variables for both tertiles and quintiles of Mn levels and included them in the adjusted regression models (we modeled tertiles separately from quintiles). We used generalized estimating equation (GEE) models to examine relationships of prenatal and postnatal dentine Mn levels with outcomes that were examined in two of the three neurobehavioral assessments.

We built separate models for behavioral, cognitive, memory, and motor outcomes, and used the same covariates in the model for all outcomes within a category. Main covariates of interest were selected using directed acyclic graphs and based on statistical considerations if covariates were associated with the exposure and any of the outcomes in the bivariate analyses (p <0.20). We retained the following variables as covariates for all analyses (modeled as shown in Table 1, unless defined below): maternal education, intelligence (PPVT score, continuous), years in the US (continuous), depression at time of assessment (dichotomous: <16 vs. ≥16 points in CES-D); child’s sex and age at neurobehavioral assessment or at maternal interview (continuous); child language of the assessment or maternal language at interview (dichotomous); psychometrician (one, two, or three categories); HOME z-score at time of assessment (continuous); household income at time of assessment, and number of children in the home at time of assessment (continuous). Missing values (<10%) for covariates were imputed using data from the nearest available visit when available or by randomly selecting a value from the dataset.

Table 1.

Study population characteristics and children’s prenatal and postnatal dentine Mn levels (55Mn:43Ca AUC × 104).

Characteristic Prenatal Mn
Postnatal Mn
n (%)a GM (95%CI) n (%)b GM (95%CI)
All participants 248 (100.0) 0.46 (0.44,0.49)     244 (100.0) 0.14 (0.13,0.16)    
Maternal characteristics
Age (years)
 18–24 91 (36.7) 0.43 (0.40,0.47)*   90 (36.9) 0.13 (0.10,0.16)**
 25–29 91 (36.7) 0.48 (0.44,0.53)     88 (36.1) 0.16 (0.14,0.18)    
 30–34 44 (17.7) 0.50 (0.44,0.56)     44 (18.0) 0.16 (0.12,0.22)    
 35–45 22 (8.9) 0.44 (0.38,0.50)     22 (9.0) 0.10 (0.06,0.18)    
Education
 ≤ 6th grade 113 (45.6) 0.51 (0.47,0.54)** 110 (45.1) 0.16 (0.13,0.19)*  
 7th–12th grade 75 (30.2) 0.46 (0.43,0.50)     75 (30.7) 0.13 (0.11,0.15)    
 Completed high school 60 (24.2) 0.39 (0.35,0.43)     59 (24.2) 0.14 (0.11,0.17)    
Intelligence (PPVT score)c
 ≤ 74 47 (19.0) 0.44 (0.39,0.49)     47 (19.2) 0.16 (0.14,0.18)    
 75–99 83 (33.4) 0.47 (0.43,0.52)     80 (32.8) 0.15 (0.12,0.18)    
 ≥ 100 118 (47.6) 0.47 (0.44,0.50)     117 (48.0) 0.13 (0.11,0.16)    
Country of birth
 Mexico 219 (88.3) 0.48 (0.45,0.50)** 215 (88.1) 0.15 (0.13,0.17)**
 Other 29 (11.7) 0.36 (0.31,0.42)     29 (11.9) 0.12 (0.10,0.14)    
Years in US
 ≤ 5 121 (48.8) 0.47 (0.44,0.51)*   119 (48.8) 0.15 (0.13,0.18)    
 6–10 67 (27.0) 0.48 (0.44,0.51)     65 (26.6) 0.14 (0.11,0.17)    
 ≥ 11 60 (24.2) 0.42 (0.38,0.47)     60 (24.6) 0.13 (0.11,0.17)    
Parity
 0 82 (33.1) 0.47 (0.43,0.51)     81 (33.2) 0.14 (0.12,0.17)    
 ≥ 1 166 (66.9) 0.46 (0.43,0.49)     163 (66.8) 0.14 (0.12,0.16)    
Smoking during pregnancy
 No 236 (95.2) 0.47 (0.45,0.49)** 232 (95.1) 0.14 (0.13,0.16)    
 Yes 12 (4.8) 0.33 (0.23,0.46)     12 (4.9) 0.14 (0.10,0.20)    
Gestational anemia (hemoglobin < 11.6 g/dL)d
 No 82 (53.2) 0.49 (0.45,0.53)     80 (53.3) 0.14 (0.11,0.18)    
 Yes 72 (46.8) 0.49 (0.44,0.54)     70 (46.7) 0.17 (0.15,0.21)    
Higher lead exposure during pregnancy (blood lead ≥ 0.8 μg/dL)d
 No 86 (50.9) 0.51 (0.47,0.55)** 85 (51.2) 0.16 (0.13,0.19)    
 Yes 83 (49.1) 0.44 (0.40,0.49)     81 (48.8) 0.14 (0.12,0.17)    
Agricultural work during pregnancyd
 No 124 (62.9) 0.45 (0.42,0.49)** 123 (63.7) 0.13 (0.11,0.16)    
 Yes 73 (37.1) 0.52 (0.48,0.57)     70 (36.3) 0.17 (0.13,0.21)    
Household income d
 At or below poverty level 118 (59.9) 0.50 (0.47,0.53)     115 (59.6) 0.14 (0.11,0.18)    
 Above poverty level 79 (40.1) 0.45 (0.41,0.49)     78 (40.4) 0.15 (0.13,0.16)    
Child characteristics
Child’s sex
 Boy 108 (43.5) 0.46 (0.43,0.49)     105 (43.0) 0.13 (0.11,0.16)    
 Girl 140 (56.5) 0.46 (0.43,0.50)     139 (57.0) 0.15 (0.13,0.17)    
Low birth weight (< 2,500 grams)
 No 235 (94.8) 0.47 (0.44,0.49)*   231 (94.7) 0.14 (0.13,0.16)    
 Yes 13 (5.2) 0.39 (0.30,0.51)     13 (5.3) 0.13 (0.09,0.18)    
Preterm birth (< 37 weeks)
 No 226 (91.1) 0.47 (0.45,0.49)*   222 (91.0) 0.14 (0.13,0.16)    
 Yes 22 (8.9) 0.39 (0.30,0.49)     22 (9.0) 0.15 (0.11,0.21)    
Cohort
 CHAM1 197 (79.4) 0.48 (0.45, 0.50)** 193 (79.1) 0.14 (0.12, 0.17)*  
 CHAM2 51 (20.6) 0.41 (0.37, 0.45)     51 (20.9) 0.13 (0.12, 0.15)    

Abbreviations: AUC, area under the curve; GM, geometric mean; CI, confidence interval; PPVT, Peabody Picture Vocabulary Test; CHAM1, initial CHAMACOS cohort (recruited 1999–2000 during pregnancy); CHAM2, second CHAMACOS cohort (recruited 2009–2011 at child age 9).

a

Children who completed the 7-, 9-, or 10.5-year neurobehavioral assessment and had prenatal dentine Mn levels measured in shed incisors.

b

Children who completed the 7-, 9-, or 10.5-year neurobehavioral assessment and had postnatal dentine Mn levels measured in shed incisors.

c

Analyzed as continuous variable in multivariable models.

d

Information was missing for several mother-child pairs with prenatal dentine (n = 51 for family income at enrollment, n = 51 for maternal agricultural work during pregnancy, n = 94 for gestational anemia, n = 79 for blood lead levels during pregnancy) and postnatal dentine Mn measurements (n = 51 for family income at enrollment, n = 51 for maternal agricultural work during pregnancy, n = 94 for gestational anemia, n = 78 for blood lead levels during pregnancy).

*

p <0.10

**

p <0.05; p-values are for Mann-Whitney or Kruskal-Wallis tests across the different categories of each characteristic.

We conducted several sensitivity analyses to assess the robustness of our results. First, we reran models after excluding outliers defined by studentized residuals (residuals divided by the model standard error) greater than three standard units. Second, we reran the analyses excluding the CHAM2 children to assess whether differences between CHAM1 and CHAM2 influenced the associations of prenatal and postnatal dentine Mn with neurodevelopmental outcomes. Third, we fitted the adjusted regression models excluding preterm (n = 22) and other low birth weight (n = 2) children given that these variables may mediate the associations between Mn exposure and neurodevelopmental outcomes. Fourth, we fitted the adjusted regression models for postnatal dentine Mn including prenatal dentine Mn as a confounder for participants with both measurements. Fifth, in the subset of CHAM1 children for whom we had measured levels during pregnancy, we examined the confounding effect of potential neurotoxicants measured during pregnancy (i.e., DAPs and PBDEs) (Bouchard et al. 2011a; Eskenazi et al. 2013; Marks et al. 2010) by adding them individually to the prenatal dentine Mn final models. We also assessed the confounding effect of lead exposure during childhood by adding child blood lead levels measured at 12 and 24 months to the postnatal dentine Mn models.

We evaluated effect modification of the associations of prenatal and postnatal dentine Mn with neurodevelopmental outcomes by child sex. Because there is evidence of synergism between lead and Mn, we also examined effect modification of the associations between prenatal dentine Mn and neurodevelopmental outcomes by prenatal lead exposure (blood lead levels above or below the median <0.8 vs. ≥0.8 μg/dL) in the subset of CHAM1 children for whom these measurements were available. Interactions were assessed using cross-product terms and were considered statistically significant if p <0.10.

3. Results

Most women in the present study were young (mean age = 26.8 ± 5.1 years at delivery of their CHAMACOS child), born in Mexico (88%), multiparous (67%), did not complete high school (76%), did not work in agriculture during pregnancy (63%), and had a family income below the U.S. poverty threshold (60%, Table 1). Many women reported sufficient symptoms at the 7- and 9-year follow-up visits to qualify as “at-risk” of depression on the CES-D scale (21% and 27%, respectively; data not shown). Geometric mean (geometric standard deviation, GSD) of prenatal and postnatal dentine Mn levels were 0.46 (1.48) and 0.14 (2.47) 55Mn:43Ca AUC × 104, respectively (Table A.1). Prenatal and postnatal dentine Mn levels were moderately correlated (rs = 0.49, p <0.001, n = 244). Maternal intelligence, parity, gestational anemia, child sex, and family income were not associated with the child’s prenatal or postnatal dentine Mn levels (Table 1). However, higher prenatal and postnatal dentine Mn levels were observed in children of mothers aged 25–34 years, born in Mexico, poorly educated, and who had lived for ≤10 years in the U.S. Higher prenatal dentine Mn levels were also found in children of mothers who worked in agriculture during pregnancy. Conversely, prenatal dentine Mn levels were lower among children whose mothers reported smoking during pregnancy, had higher blood lead levels during pregnancy (≥0.8 μg/dL), and low birth weight or preterm children. CHAM1 and CHAM2 families were similar demographically (comparisons not shown), but CHAM1 children showed higher prenatal and early postnatal Mn levels in dentine compared to CHAM2 children (Table 1). Summary statistics for the children’s performance on the various neurobehavioral tests are presented in Table A.2.

In our cubic spline analysis, we found evidence of a small number of nonlinear associations of dentine Mn levels with neurodevelopmental outcomes (marked with pGAM <0.05), but when we categorized Mn levels in either tertiles or quintiles we did not observe clear dose-response relationships (data not shown). We therefore report results from multivariate linear regression and GEE models with prenatal and postnatal dentine Mn levels parameterized as continuous variables.

3.1. Behavior

Prenatal Mn

No associations were observed between prenatal dentine Mn levels and behavioral outcomes at ages 7, 9, or 10.5 years in cross-sectional (Table 2) or longitudinal (Table A.3) analyses of boys and girls combined. However, when we stratified by child sex, we found that higher prenatal dentine Mn levels were associated with more frequent maternal reports of internalizing, externalizing, and hyperactivity problems on BASC-2 at age 10.5 years among boys [β for a two-fold increase in Mn levels = 4.0, 95% Confidence Interval (CI): 0.6, 7.4; β = 2.7, 95% CI: −0.2, 5.6; and β = 3.7, 95% CI: 0.2, 7.2; respectively] but not among girls (Table 2). We also observed that higher prenatal dentine Mn levels were associated with more frequent maternal reports of internalizing problems on BASC-2 at ages 7 (β = 3.9, 95% CI: −0.5, 8.4) and 10.5 years (β = 5.1, 95% CI: 1.9, 8.3), but less frequent teacher reports of inattention on CADS at age 7 years (β =−2.4, 95% CI: −7.0, 2.1), among children with lower prenatal lead levels (<0.8 μg/dL; Table A.4).

Table 2.

Adjusted linear models for behavioral outcomes in children at 7, 9, and 10.5 years, per two-fold increase in prenatal dentine Mn (55Mn:43Ca AUC × 104) in all children and stratified by sex.

Outcomesa All children
Boys
Girls
pINT
n β (95% CI) n β (95% CI) n β (95% CI)
7-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 198 −0.7 (−2.4,1.1)     83 0.9 (−1.9,3.8)     115 −1.3 (−3.9,1.3)     0.12
 DSM-IV total scale 198 −1.3 (−2.9,0.4)     83 −0.5 (−3.4,2.4)     115 −1.5 (−4.0,0.9)     0.40
  Inattentive subscale 198 −1.4 (−3.0,0.1)*   83 −0.3 (−3.2,2.5)     115 −2.2 (−4.4,0.1)*   0.18
  Hyperactive/impulsive subscale 198 −1.1 (−2.9,0.7)     83 −0.5 (−3.5,2.6)     115 −1.1 (−3.5,1.4)     0.60
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 193 0.4 (−1.7,2.5)     83 1.5 (−1.6,4.6)     110 −0.5 (−3.8,2.7)     0.19
 Externalizing problems 193 −0.3 (−2.2,1.6)     83 0.9 (−2.4,4.1)     110 −0.7 (−3.3,1.9)     0.43
  Attention problems 193 0.4 (−2.3,3.0)     83 0.6 (−2.3,3.6)     110 0.7 (−1.8,3.3)     0.91
  Hyperactivity 193 0.4 (−1.4,2.3)     83 1.5 (−2.6,5.7)     110 −0.3 (−3.8,3.3)     0.35
CADS - Teacher report (T-scores)c
 ADHD Index 170 −1.0 (−3.5,1.5)     70 0.6 (−3.2,4.4)     100 -1.9 (−5.7,2.0)     0.29
 DSM-IV total scale 170 −0.1 (−2.3,2.1)     70 0.8 (−2.4,4.1)     100 −0.6 (−4.1,2.8)     0.50
  Inattentive subscale 173 0.8 (−1.1,2.6)     71 1.3 (−2.2,4.8)     102 0.7 (−1.6,3.0)     0.71
  Hyperactive/impulsive subscale 173 −1.2 (−3.6,1.1)     71 0.1 (−3.5,3.6)     102 −2.0 (−5.5,1.6)     0.45
BASC-2 - Teacher report (T-scores)c
 Internalizing problems 173 −2.8 (−6.2,0.5)*   71 −2.1 (−5.6,1.4)     102 −3.8 (−9.0,1.5)     0.55
 Externalizing problems 173 −0.5 (−2.6,1.6)     71 0.1 (−4.2,4.4)     102 −1.1 (−3.8,1.5)     0.88
  Attention problems 173 −0.7 (−2.3,0.9)     71 0.1 (−4.3,4.5)     102 −2.0 (−4.6,0.6)     0.66
  Hyperactivity 173 −1.0 (−3.2,1.1)     71 −0.6 (−3.2,2.0)     102 −0.5 (−2.7,1.6)     0.74
9-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 243 0.1 (−1.8,2.1)     107 2.0 (−0.9,4.9)     136 −0.5 (−3.5,2.6)     0.17
 DSM-IV total scale 242 0.8 (−1.5,3.0)     107 2.8 (−0.5,6.0)*   136 0.0 (−3.4,3.5)     0.29
  Inattentive subscale 242 0.3 (−1.7,2.2)     107 1.6 (−1.1,4.3)     136 −0.2 (−3.4,2.9)     0.30
  Hyperactive/impulsive subscale 242 1.1 (−1.5,3.7)     107 3.7 (−0.4,7.7)*   136 0.2 (−3.7,4.2)     0.35
CPT-II (T-scores)d
 Errors of omission 238 −2.0 (−7.0,3.0)     104 −5.1 (−11.6,1.5)     134 −0.4 (−7.4,6.6)     0.22
 Errors of commission 238 −2.0 (−4.2,0.2)*   104 −2.4 (−6.2,1.4)     134 −2.2 (−5.2,0.8)     0.49
 ADHD Confidence index 238 −3.0 (−8.7,2.7)     104 −10.0 (−17.2, −2.7)** 134 3.2 (−5.0,11.3)     0.01
10.5-year assessment
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 232 1.0 (−1.0,2.9)     99 4.0 (0.6,7.4)** 133 0.3 (−2.3,2.8)     0.12
 Externalizing problems 227 0.6 (−1.0,2.2)     96 2.7 (−0.2,5.6)*   131 0.0 (−2.0,2.0)     0.10
   Attention problems 232 0.1 (−2.2,2.4)     99 1.0 (−1.8,3.9)     133 0.2 (−1.7,2.2)     0.79
  Hyperactivity 232 0.1 (−1.4,1.7)     99 3.7 (0.2,7.2)** 133 −1.7 (−4.8,1.3)     0.02
BASC-2 - Self-report (T-scores)d
 Attention problems 225 −0.5 (−2.9,1.8)     98 −0.6 (−5.2,4.0)     130 −0.7 (−3.8,2.3)     0.87
 Hyperactivity 228 −0.9 (−3.6,1.8)     97 1.5 (−3.2,6.1)     128 −1.2 (−3.9,1.5)     0.22

Abbreviations: AUC, area under the curve; CADS, Conners’ ADHD/DSM-IV Scales; ADHD, Attention Deficit/Hyperactivity Disorder; BASC-2, Behavior Assessment System for Children 2nd edition; CPT-II, Continuous Performance Test 2nd edition.

a

Higher scores indicate poorer performance or more symptomatic behavior.

b

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at maternal interview; language of maternal interview; HOME z-score, household income, and number of children in the home at time of assessment.

c

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at interview; HOME z-score, household income, and number of children in the home at time of assessment.

d

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05

#

pGAM <0.05.

Postnatal Mn

Higher postnatal dentine Mn levels were associated with more frequent maternal reports of behavioral problems at 7 years in cross-sectional analyses of boys and girls combined (Table 3). Effect sizes were small, but stronger for select BASC-2 outcomes, specifically internalizing problems (β = 0.8, 95% CI: 0.0, 1.6), externalizing problems (β = 0.6, 95% CI: 0.0, 1.2), and hyperactivity (β = 0.8, 95% CI: 0.1, 1.4). Similarly, adjusted GEE analyses of repeated behavior measures at ages 7 and 10.5 years showed that higher postnatal dentine Mn levels were related to slightly worse internalizing (β = 0.6, 95% CI: 0.0, 1.2) and externalizing problems (β = 0.4, 95% CI: −0.1, 0.8) BASC-2 scores (Table A.3). We did not observe consistent sex differences in the associations between postnatal dentine Mn levels and behavioral outcomes (Table 2).

Table 3.

Adjusted linear models for behavioral outcomes in children at 7, 9, and 10.5 years, per two-fold increase in postnatal dentine Mn (55Mn:43Ca AUC × 104) in all children and stratified by sex.

Outcomesa All children
Boys
Girls
pINT
n β (95% CI) n β (95% CI) n β (95% CI)
7-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 194 0.4 (−0.3,1.1)     80 0.7 (−0.2,1.6)     114 0.3 (−0.9,1.6)     0.87
 DSM-IV total scale 194 0.5 (−0.1,1.1)     80 0.5 (−0.4,1.5)     114 0.6 (−0.3,1.5)     0.80
  Inattentive subscale 194 0.2 (−0.4,0.8)     80 0.6 (−0.2,1.5)     114 0.1 (−0.9,1.0)     0.62
  Hyperactive/impulsive subscale 194 0.7 (0.1,1.3)** 80 0.5 (−0.5,1.5)     114 0.8 (0.0,1.6)** 0.60
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 189 0.8 (0.0,1.6)** 80 1.6 (0.8,2.4)** 109 0.4 (−0.7,1.4)     0.13
 Externalizing problems 189 0.6 (0.0,1.2)** 80 0.9 (−0.1,1.9)*   109 0.5 (−0.3,1.3)     0.40
  Attention problems 189 −0.1 (−1.2,1.0)     80 0.6 (−0.4,1.7)     109 1.0 (0.1,1.8)** 0.67
  Hyperactivity 189 0.8 (0.1,1.4)** 80 −0.4 (−1.7,0.8)     109 0.8 (−0.7,2.3)     0.16
CADS - Teacher report (T-scores)c
 ADHD Index 166 0.0 (−1.5,1.6)     67 0.0 (−2.3,2.2)     99 0.0 (−2.1,2.1)     0.89
 DSM-IV total scale 166 0.1 (−1.2,1.4)     67 0.1 (−1.8,1.9)     99 0.0 (−1.8,1.9)     0.81
  Inattentive subscale 169 0.4 (−0.7,1.5)     68 0.3 (−1.5,2.0)     101 0.4 (−0.9,1.8)     0.96
  Hyperactive/impulsive subscale 169 −0.1 (−1.4,1.2)     68 −0.1 (−2.2,2.0)     101 −0.5 (−2.4,1.4)     0.53
BASC-2 - Teacher report (T-scores)c
 Internalizing problems 169 −0.3 (−1.7,1.1)     68 0.3 (−0.9,1.5)     101 −0.9 (−4.2,2.3)     0.43
 Externalizing problems 169 0.0 (−1.3,1.2)     68 −0.2 (−2.6,2.1)     101 −0.1 (−1.4,1.2)     0.95
  Attention problems 169 0.0 (−1.1,1.1)     68 −0.3 (−3.0,2.5)     101 −0.5 (−2.2,1.2)     0.74
  Hyperactivity 169 −0.2 (−1.7,1.2)     68 −0.3 (−1.8,1.1)     101 0.3 (−0.9,1.6)     0.56
9-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 239 0.1 (−0.6,0.8)     104 0.3 (−0.7,1.3)     135 0.1 (−0.9,1.1)     0.90
 DSM-IV total scale 238 0.3 (−0.4,1.0)     104 0.0 (−1.0,1.1)     134 0.6 (−0.4,1.6)     0.36
  Inattentive subscale 238 0.2 (−0.5,0.8)     104 −0.1 (−1.1,0.9)     134 0.5 (−0.4,1.5)     0.29
  Hyperactive/impulsive subscale 238 0.3 (−0.5,1.1)     104 0.1 (−1.1,1.4)     134 0.5 (−0.6,1.7)     0.53
CPT-II (T-scores)d
 Errors of omission 234 0.2 (−0.9,1.3)     101 −0.7 (−2.4,0.9)     133 0.5 (−1.0,1.9)     0.27
 Errors of commission 234 −0.1 (−0.8,0.5)     101 −0.5 (−1.4,0.4)     133 0.3 (−0.5,1.1)     0.54
 ADHD Confidence index 234 0.5 (−1.1,2.0)     101 −1.2 (−3.2,0.8)     133 1.3 (−0.8,3.4)     0.07
10.5-year assessment
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 228 0.4 (−0.3,1.2)     96 0.6 (−0.8,2.0)     132 0.3 (−0.5,1.1)     0.76
 Externalizing problems 224 0.3 (−0.3,0.8)     93 0.6 (−0.5,1.7)     131 0.3 (−0.3,0.8)     0.90
  Attention problems 228 0.3 (−0.5,1.0)     96 −0.2 (−1.4,0.9)     132 0.1 (−0.4,0.7)     0.51
Hyperactivity 228 −0.1 (−0.6,0.5)     96 0.4 (−1.0,1.7)     132 0.1 (−1.0,1.2)     0.56
BASC-2 - Self-report (T-scores)d
 Attention problems 221 −0.2 (−0.9,0.4)     95 0.1 (−1.2,1.4)     129 −0.1 (−1.1,0.9)     0.89
 Hyperactivity 224 −0.1 (−0.7,0.6)     94 0.2 (−1.0,1.4)     127 −0.2 (−1.0,0.7)     0.86

Abbreviations: AUC, area under the curve; CADS, Conners’ ADHD/DSM-IV Scales; ADHD, Attention Deficit/Hyperactivity Disorder; BASC-2, Behavior Assessment System for Children 2nd edition; CPT-II, Continuous Performance Test 2nd edition.

a

Higher scores indicate poorer performance or more symptomatic behavior.

b

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at maternal interview; language of maternal interview; HOME z-score, household income, and number of children in the home at time of assessment.

c

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at interview; HOME z-score, household income, and number of children in the home at time of assessment.

d

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05

#

pGAM <0.05.

3.2. Cognition

Prenatal Mn

No consistent and statistically significant associations between prenatal dentine Mn levels and cognitive outcomes were observed in cross-sectional (Table 4) or longitudinal (Table A.3) analyses of boys and girls combined. However, when we stratified by child sex, we observed that higher prenatal dentine Mn levels were associated with better cognitive outcomes at 7 and 10.5 years among boys than among girls, although these sex differences were not statistically significant (Table 4). In contrast, we found consistent associations of higher prenatal Mn levels with worse cognitive outcomes at ages 7 and 10.5 years among children with higher prenatal lead blood levels (≥0.8 μg/dL; Figure 1 and Table A.5). For example, higher prenatal dentine Mn levels were associated with 3.5-point (95% CI: −7.2, 0.2) and 3.7-point (95% CI: −7.7, 0.2) decreases in Full Scale IQ scores at 7 and 10.5 years, respectively, but only among children with higher prenatal lead exposures.

Table 4.

Adjusted linear models for cognitive, memory, and motor outcomes in children at 7, 9, and 10.5 years, per two-fold increase in prenatal dentine Mn (55Mn:43Ca AUC × 104) in all children and stratified by sex.

Outcomes All children
Boys
Girls
pINT
n β (95% CI) n β (95% CI) n β (95% CI)
Cognition
7-year assessment
WISC-IV Full-Scale IQ (scaled scores)     175 0.8 (−2.4,3.9)     76 3.2 (−1.3,7.8)     99 −0.6 (−5.2,4.0)     0.22
 Verbal Comprehension IQ 193 0.9 (−2.0,3.8)     83 1.2 (−2.8,5.1)     110 0.6 (−3.4,4.7)     0.84
 Perceptual Reasoning IQ 193 2.2 (−2.7,7.0)#   83 4.7 (−4.2,13.7)     110 0.7 (−5.5,6.9)     0.42
 Working Memory IQ 176 0.7 (−2.4,3.8)     76 2.7 (−2.7,8.0)     100 −0.2 (−4.2,3.7)     0.40
 Processing Speed IQ 176 1.6 (−1.6,4.7)     76 4.2 (−1.0,9.3)     100 −0.3 (−4.1,3.5)     0.12
10.5-year assessment
WISC-IV Full-Scale IQ (scaled scores)     231 1.2 (−1.2,3.6)     98 1.1 (−3.0,5.1)     133 0.3 (−3.1,3.6)     0.42
 Verbal Comprehension IQ 233 −0.4 (−2.5,1.8)     100 −2.0 (−5.6,1.7)     133 −0.7 (−3.5,2.1)     0.94
 Perceptual Reasoning IQ 233 3.0 (−0.8,6.7)     100 3.8 (−3.6,11.1)     133 1.7 (−3.1,6.4)     0.32
 Working Memory IQ 233 1.4 (−0.9,3.6)     100 1.6 (−2.4,5.6)     133 0.4 (−2.7,3.4)     0.48
 Processing Speed IQ 233 0.0 (−2.7,2.7)     100 1.0 (−3.5,5.5)     133 −0.7 (−4.5,3.1)     0.51
Memory
9-year assessment
NEPSY-II Memory for Designs (scaled scores)    
 Immediate total 184 0.8 (−0.2,1.8)     78 1.9 (0.8,3.0)** 106 0.3 (−1.2,1.9)     0.31
 Delayed total 185 1.0 (0.0,1.9)** 78 2.2 (0.7,3.7)** 107 0.3 (−1.1,1.6)     0.17
10.5-year assessment
CAVLT-2 (standardized scores)    
 Immediate recall 233 2.1 (−2.4,6.6)#   100 4.3 (−0.9,9.4)     133 −0.3 (−7.2,6.6)     0.25
 Delayed recall 233 3.8 (−0.4,8.0)*   100 6.2 (0.7,11.8)** 133 1.4 (−4.8,7.6)     0.18
 Immediate memory span 233 −0.9 (−4.3,2.5)     100 −4.4 (−9.9,1.1)     133 0.8 (−3.7,5.3)     0.18
 Level of learning 233 3.8 (0.0,7.6)** 100 4.7 (−1.1,10.6)     133 2.6 (−2.2,7.4)     0.61
Motor function
7-year assessment
WRAVMA Pegboard (scaled scores)    
 Dominant hand 193 1.9 (−2.5,6.3)     83 2.1 (−5.1,9.3)     110 2.5 (−3.3,8.3)     0.48
 Non-dominant hand 193 2.0 (−2.5,6.5)     83 2.6 (−4.3,9.6)     110 2.1 (−4.1,8.3)     0.66
Finger Tap (z-scores)    
 Dominant hand 193 0.2 (0.0,0.4)*   83 0.5 (0.1,0.8)** 110 0.1 (−0.2,0.4)     0.04
 Non-dominant hand 193 0.1 (−0.2,0.3)     83 0.3 (0.0,0.7)*   110 −0.1 (−0.4,0.2)     0.01
9-year assessment
Luria-Nebraska Motor Scale (z-scores)    
 All items 227 0.1 (−0.1,0.3)     100 0.3 (−0.1,0.6)     127 0.0 (−0.3,0.3)     0.02
 5-item sum 227 0.1 (−0.1,0.3)     100 0.3 (0.0,0.6)*   127 0.0 (−0.3,0.2)     0.01
10.5-year assessment
Luria-Nebraska Motor Scale (z-scores)    
 All items 233 0.1 (0.0,0.3)     100 0.3 (0.1,0.5)** 133 0.0 (−0.3,0.2)     0.01
 5-item sum 233 0.2 (0.0,0.4)*   100 0.5 (0.2,0.8)** 133 0.0 (−0.4,0.3)     0.02

Abbreviations: CI, confidence interval; WISC-IV, Wechsler Intelligence Scale for Children 4th edition; IQ, intellectual quotient; CAVLT-2, Children’s Auditory Verbal Learning Test 2nd edition; WRAVMA, Wide Range Assessment of Visual Motor Ability.

Models adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05

#

pGAM <0.05.

Figure 1.

Figure 1

Adjusted linear models for WISC-IV Full Scale IQ at 7 years and NEPSY-II Memory for Designs Delayed Memory at 9 years per two-fold increase in prenatal dentine Mn (55Mn:43Ca AUC × 104) stratified by prenatal lead exposure (maternal blood Pb levels during pregnancy <0.8 vs. ≥0.8 μg/dL).

Models adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

Postnatal Mn

We did not find statistically significant associations between postnatal dentine Mn levels and cognitive outcomes in the analyses of boys and girls combined, but we did observe significant interactions between postnatal Mn levels and child sex for most cognitive outcomes (Table 5). More specifically, we found a positive linear relationship of postnatal dentine Mn levels with Full Scale, Verbal Comprehension, and Perceptual Reasoning IQ scores at 7 and 10.5 years, and Working Memory IQ scores at 7 years, in boys but not girls. For instance, a two-fold increase in postnatal Mn levels was associated with 1.9-point (95% CI: 0.6, 3.1) and 2.0-point (95% CI: 0.7, 3.3) increases in Full Scale IQ scores at 7 and 10.5 years, respectively, in boys but not girls.

Table 5.

Adjusted linear models for cognitive, memory, and motor outcomes in children at 7, 9, and 10.5 years, per two-fold increase in postnatal dentine Mn (55Mn:43Ca AUC × 104) in all children and stratified by sex.

Outcomes All children
Boys
Girls
p INT
n β (95% CI) n β (95% CI) n β (95% CI)
Cognition
7-year assessment
WISC-IV Full-Scale IQ (scaled scores)     171 0.5 (−0.7,1.6)     73 1.9 (0.6,3.1)** 98 −0.3 (−2.1,1.6)     0.12
 Verbal Comprehension IQ 189 0.6 (−0.3,1.6)     80 1.6 (0.1,3.1)** 109 0.3 (−1.3,1.9)     0.50
 Perceptual Reasoning IQ 189 0.7 (−0.8,2.2)     80 3.4 (1.6,5.2)** 109 −1.1 (−3.1,0.9)     <0.01  
 Working Memory IQ 172 0.4 (−1.0,1.8)     73 1.5 (0.5,2.6)** 99 −0.4 (−2.5,1.7)     0.16
 Processing Speed IQ 172 0.5 (−0.9,1.8)     73 −0.3 (−2.6,2.0)     99 1.3 (−0.3, 2.8)     0.11
10.5-year assessment
WISC-IV Full-Scale IQ (scaled scores)     227 0.7 (−0.3,1.8)     95 2.0 (0.7,3.3)** 132 −0.2 (−1.5.5,1.2)     0.01
 Verbal Comprehension IQ 229 0.6 (−0.6,1.7)     97 1.5 (0.2,2.9)** 132 −0.4 (−1.7,0.8)     <0.01  
 Perceptual Reasoning IQ 229 1.2 (−0.3,2.6)     97 3.3 (1.3,5.4)** 132 −0.2 (−2.0,1.5)     0.01
 Working Memory IQ 229 0.7 (−0.2,1.7)     97 0.9 (−0.5,2.3)     132 0.7 (−0.8,2.1)     0.78
 Processing Speed IQ 229 −0.5 (−1.5,0.5)     97 0.2 (−1.5,1.8)     132 −0.6 (−2.1,0.9)     0.72
Memory
9-year assessment
NEPSY-II Memory for Designs (scaled scores)    
 Immediate total 180 0.1 (−0.3,0.5)#   75 0.5 (0.1,1.0) ** 105 −0.3 (−0.8,0.3)     0.02
 Delayed total 181 0.0 (−0.5,0.5)#   75 0.4 (−0.4,1.2)     106 −0.3 (−0.9,0.4)     0.25
10.5-year assessment
CAVLT-2 (standardized scores)    
 Immediate recall 229 0.9 (−1.2,3.1)     97 2.9 (0.7,5.2)** 132 −0.7 (−4.1,2.7)     0.08
 Delayed recall 229 1.3 (−1.4,3.9)     97 3.0 (0.3,5.6)** 132 −0.1 (−4.7,4.6)     0.24
 Immediate memory span 229 0.8 (−1.0,2.6)     97 1.8 (−0.7,4.2)     132 −0.2 (−2.8,2.4)     0.28
 Level of learning 229 1.1 (−0.8,3.0)     97 2.6 (0.5,4.8)** 132 −0.4 (−2.8,2.1)     0.08
Motor function
7-year assessment
WRAVMA Pegboard (scaled scores)    
 Dominant hand 189 −0.4 (−2.0,1.2)     80 0.0 (−1.9,1.8)     109 −1.3 (−4.1,1.6)     0.44
 Non-dominant hand 189 0.1 (−1.8,2.1)     80 1.4 (−0.4,3.2)     109 −1.8 (−4.2,0.6)     0.04
Finger Tap (z-scores)    
 Dominant hand 189 0.1 (0.0,0.1)     80 0.2 (0.1,0.3)** 109 0.0 (−0.2,0.1)     0.03
 Non-dominant hand 189 0.0 (−0.1,0.1)     80 0.1 (0.0,0.2)     109 0.0 (−0.2,0.1)     0.19
9-year assessment
Luria-Nebraska Motor Scale (z-scores)    
 All items 223 −0.1 (−0.1,0.0)     97 0.0 (−0.1,0.1)     126 −0.1 (−0.2,0.1)     0.36
 5-item sum 223 −0.1 (−0.1,0.0)     97 0.0 (−0.1,0.1)     126 −0.1 (−0.2,0.1)     0.28
10.5-year assessment
Luria-Nebraska Motor Scale (z-scores)    
 All items 229 0.0 (−0.1,0.1)     97 0.1 (0.0,0.1)     132 −0.1 (−0.1,0.0)*   <0.01  
 5-item sum 229 0.0 (−0.1,0.0)     97 0.1 (−0.1,0.2)     132 −0.1 (-0.2,0.0)*   0.09

Abbreviations: CI, confidence interval; WISC-IV, Wechsler Intelligence Scale for Children 4th edition; IQ, intellectual quotient; CAVLT-2, Children’s Auditory Verbal Learning Test 2nd edition; WRAVMA, Wide Range Assessment of Visual Motor Ability.

Models adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05

#

pGAM <0.05.

Adjusted GEE analyses of repeated outcome measures in boys and girls combined did not show associations between postnatal dentine Mn levels and cognitive outcomes (Table A.3). However, when we stratified GEE analyses by child sex, we observed that higher postnatal Mn levels were associated with better Full Scale (β = 1.7, 95% CI: 0.3, 3.1), Verbal Comprehension (β = 1.4, 95% CI: 0.6, 2.1), Perceptual Reasoning (β = 2.8, 95% CI: 0.6, 5.1), and Working Memory IQ scores (β = 1.2, 95% CI: 0.1, 2.2) in boys but not girls (β =−0.1, 95% CI: −1.3, 1.2, pINT = 0.05; β = 0.2, 95% CI: −0.9, 1.2, pINT = 0.10; β = −0.7, 95% CI: −2.1, 0.7, pINT = 0.01; β = 0.1, 95% CI: −1.3, 1.4, pINT = 0.32; respectively, data not shown).

3.3. Memory

Prenatal Mn

Higher prenatal dentine Mn levels were linearly associated with better memory outcomes at ages 9 and 10.5 years in the analyses of boys and girls combined (Table 4). A two-fold increase in prenatal dentine Mn levels was associated with a 1.0-point increase in NEPSY-II Memory for Designs Delayed total score (95% CI: 0.0, 1.9) at 9 years, and 3.8-point increases in CAVLT-2 Delayed recall (95% CI: −0.4, 8.0) and Level of learning scores (95% CI: 0.0, 7.6) at 10.5 years. In sex-stratified analyses, we observed that higher prenatal dentine Mn levels were associated with better NEPSY-II Memory for Designs Immediate (β = 1.9, 95% CI: 0.8, 3.0) and Delayed total scores (β = 2.2, 95% CI: 0.7, 3.7) at 9 years and improved CAVLT-2 Delayed recall scores (β = 6.2, 95% CI: 0.7, 11.8) at 10.5 years in boys but not in girls (Table 4), but these sex differences were not statistically significant. Conversely, we also found that higher prenatal dentine Mn levels were associated with poorer NEPSY-II Memory for Designs Delayed total scores (β = −1.2, 95% CI: −2.4, 0.0) at 9 years in children with higher prenatal lead levels, but not in those with lower lead levels (Figure 1 and Table A.5).

Postnatal Mn

Postnatal dentine Mn levels were not linearly associated with any of the memory outcomes in combined analyses across child sex (Table 5). However, sex-stratified analyses revealed that higher postnatal dentine Mn levels were significantly associated with better memory scores at ages 9 and 10.5 years in boys, but not girls (Table 5). A two-fold increase in postnatal Mn levels was associated with a 0.5-point increase in NEPSY-II Memory for Designs Immediate total score (95% CI: 0.1, 1.0) at 9 years, and 2.9-point increase in CAVLT-2 Immediate recall score (95% CI: 0.7, 5.2), 3.0-point increase in CAVLT-2 Delayed recall score (95% CI: 0.3, 5.6), and a 2.6-point increase in CAVLT-2 Level of learning score (95% CI: 0.5, 4.8) at 10.5 years in boys.

3.4. Motor function

Prenatal Mn

No consistent and statistically significant associations between prenatal dentine Mn levels and motor outcomes were observed in the cross-sectional (Table 4) or longitudinal analyses (Table A.3) that combined boys and girls. However, when we stratified by child sex, we found that higher prenatal dentine Mn levels were associated with better z-scores on the Finger tapping test for both dominant (β = 0.5, 95% CI: 0.1, 0.8) and non-dominant hands (β = 0.3, 95% CI: 0.0, 0.7) at age 7, all-item (β = 0.3, 95% CI: −0.1, 0.6) and five-item sum (β = 0.3, 95% CI: 0.0, 0.6) of the Luria-Nebraska Motor Scale at age 9, and all-item (β = 0.3, 95% CI: 0.1, 0.5) and five-item sum (β = 0.5, 95% CI: 0.2, 0.8) of the Luria-Nebraska Scale at age 10.5 in boys compared to girls (Table 4). When we stratified GEE analyses by child sex, we observed that higher prenatal Mn levels were associated with better z-scores on the all-item (β = 0.3, 95% CI: 0.1, 0.5) and five-item sum (β = 0.4, 95% CI: 0.2, 0.6) of the Luria-Nebraska Motor Scale in boys but not girls (β = 0.0, 95% CI: −0.2, 0.2, pINT <0.01; β = 0.0, 95% CI: −0.3, 0.3, pINT <0.01; respectively, data not shown).

Postnatal Mn

We did not find statistically significant associations between postnatal dentine Mn levels and motor outcomes in cross-sectional (Table 5) or longitudinal analyses (Table A.3) that combined boys and girls, but we observed several significant associations in the sex-stratified analyses (Table 5). Higher postnatal Mn levels were associated with better scores on the WRAVMA pegboard (non-dominant hand: β = 1.4, 95% CI: −0.4, 3.2) and Finger tapping test (dominant hand: β = 0.2, 95% CI: 0.1, 0.3) at 7 years, and Luria-Nebraska Motor Scale (all-item sum: β = 0.1, 95% CI: 0.0, 0.1; five-item sum: β = 0.1, 95% CI: −0.1, 0.2) at 10.5 years in boys than in girls (Table 5).

3.5. Sensitivity analyses

In general, the point estimates did not change appreciably after removal of the outliers from the final multivariable models. Restricting the analyses to CHAM1 children yielded results similar to those obtained for the entire group. Including prenatal dentine Mn levels in the adjusted models for postnatal Mn levels and excluding preterm and other low birth weight children from the analyses only marginally altered the results (change in estimates <10%). Similarly, including prenatal DAPs and child blood lead levels measured at 12 and 24 months in the adjusted models did not change the point estimates observed in the main analyses (data not shown). However, when we included prenatal PBDE levels in the models, we observed that some associations that were not previously statistically significant became significant: higher prenatal dentine Mn levels were associated with less frequent teacher reports of hyperactivity problems (β for a two-fold increase in Mn levels = −1.9, 95% CI: −4.1, 0.3) on BASC-2, lower teacher ADHD Index (β = −2.4, 95% CI: −5.1, 0.2) and Hyperactive/impulsive scores (β = −2.6, 95% CI: −5.1, −0.1) on CADS at age 7, and lower errors of omission (β = −5.7, 95% CI: −12.5, 1.2) and ADHD Confidence index scores (β = −7.7, 95% CI: −14.7, −0.8) on CPT-II at age 9 (data not shown). Notably, the associations that we observed between prenatal and postnatal Mn levels and maternal reports of behavioral problems at ages 7 and 10.5 years remained unchanged when we included prenatal PBDE levels in the models.

4. Discussion

We found that prenatal and early postnatal Mn levels in dentine of deciduous teeth were adversely associated with behavioral outcomes, namely maternal-reported internalizing, externalizing, and hyperactivity problems, in school-age boys and girls. In contrast, we observed that prenatal and postnatal Mn dentine levels were favorably associated with several measures of cognition, visuospatial and verbal memory, and motor function in boys. We also found that higher prenatal Mn levels were associated with poorer visuospatial memory and cognition in children exposed to higher prenatal lead levels. Our results appeared to be independent of the associations of prenatal OP pesticide and PBDE exposure with child neurobehavioral development that have been previously reported in the CHAMACOS cohort (Bouchard et al. 2011a; Marks et al. 2010); Eskenazi et al. 2013).

To our knowledge, this is the largest and most comprehensive study to date on the potential neurodevelopmental effects of prenatal and early postnatal Mn status in school-age children. Few studies have prospectively examined the associations between in utero and/or postnatal exposure to Mn and neurobehavioral outcomes (Chung et al. 2015; Ericson et al. 2007; Lin et al. 2013; Takser et al. 2003) and there are some consistencies between their findings and ours. A small study of 27 U.S. children observed that higher prenatal Mn levels in enamel of deciduous teeth were associated with poorer performance in behavioral disinhibition tests at ages 3 and 4.5 years (including increased errors of commission on a continuous performance test), and more adverse maternal and teacher reports of internalizing and externalizing problems at ages 6–7 (1st grade) and 8–9 years (3rd grade) (Ericson et al. 2007). This study also found a positive association between early postnatal enamel Mn levels and teacher-reported scores of externalizing problems at ages 6–7 and 8–9 years. Unlike numerous cross-sectional studies of school-age children that reported negative associations between Mn levels and cognition (Bouchard et al. 2011b; He et al. 1994; Hernandez-Bonilla et al. 2011; Kim et al. 2009; Lucchini et al. 2012; Menezes-Filho et al. 2011; Riojas-Rodriguez et al. 2010; Torres-Agustin et al. 2013; Wasserman et al. 2006), a cohort study of 247 French children did not find significant adverse associations of maternal and child Mn levels at delivery with cognitive abilities assessed at ages 3 and 6 years (Takser et al. 2003), while we observed beneficial associations among boys.

Although our study shows some consistencies with previous prospective studies, there are also some inconsistencies. For example, a study of 232 Korean mother-child pairs observed inverted U-shaped relationships of maternal blood Mn levels measured at delivery with mental and psychomotor development at 6 months (Chung et al. 2015), but we did not observe nonlinear associations or clear dose-response relationships in our analyses. A study of 230 children conducted in Taiwan reported an association of cord blood Mn levels above the 75th percentile (>59.3 μg/L) with poorer cognitive and language development at 2 years of age (Lin et al. 2013), whereas, in our study, we observed positive associations of prenatal and postnatal dentine Mn levels with cognitive abilities among boys. In addition, the French study observed that higher cord blood Mn levels were associated with lower non-verbal memory (in boys and girls combined) and hand skill scores (in boys only) at age 3 years (Takser et al. 2003); however, in our study, prenatal and postnatal dentine Mn levels were consistently associated with better memory and motor outcomes scores in somewhat older boys. These inconsistent findings may be due to differences in the exposure matrix used to quantify Mn levels (blood and hair samples vs. dentine of deciduous teeth) or Mn exposure pathways [inhalation vs. dietary and non-dietary (i.e., hand-to-mouth) ingestion]. Discrepancies between previous studies and ours may also be due to the fact that dentine Mn levels in our study population could be within the range at which Mn acts as a nutrient in a beneficial capacity rather than a neurotoxicant, thus resulting in improved neurodevelopmental outcomes. Because no other studies have measured Mn levels in dentine using the same analytical method, we were not able to compare our dentine Mn levels with those reported previously (Battistone et al. 1967; Lappalainen and Knuuttila 1982). Nevertheless, based on a small number of samples that were analyzed for Mn (Gunier et al. 2014), it seems that maternal and cord blood Mn levels detected in our study population are comparable to those observed in other prospective studies (Chung et al. 2015; Lin et al. 2013; Takser et al. 2003).

Previous cross-sectional studies have reported stronger negative associations of Mn levels with behavior, cognitive, memory, and motor outcomes for girls than for boys (Bouchard et al. 2011a; Hernandez-Bonilla et al. 2011; Menezes-Filho et al. 2013; Riojas-Rodriguez et al. 2010; Torres-Agustin et al. 2013). Our study did not show negative associations between prenatal or postnatal dentine Mn levels and these outcomes for girls, but instead we observed several positive and significant associations for boys. Biological differences in response to Mn may explain differences between boys and girls. Animal studies have shown that Mn accumulation across body tissues (Dorman et al. 2004) and changes in striatal morphology (Madison et al. 2011) differ between male and female rodents. Further animal and epidemiologic studies are needed to elucidate possible biological differences between males and females.

Several epidemiologic studies have shown that lead can modify the association between Mn exposure and neurodevelopment (Claus Henn et al. 2012; Kim et al. 2009; Lin et al. 2013). For example, a study of 455 Mexican children observed greater deficits in both mental and psychomotor development at ages 12–36 months in children with the highest 12-month blood Mn and lead levels compared to those with lower levels of both metals (Claus Henn et al. 2012). Similarly, a recent study of 230 children in Taiwan reported significantly lower cognitive, language, and overall development quotients at 2 years of age in the group with the highest cord blood Mn and cord blood lead levels (≥75th percentile for both metals) compared to the group with the lowest cord blood Mn and lead levels (<25th percentile for both metals) (Lin et al. 2013). In the present study, we observed that higher prenatal Mn levels were associated with poorer visuospatial memory outcomes at 9 years and worse cognitive scores at 7 and 10.5 years in children with higher prenatal lead levels (≥0.8 μg/dL) but not in children with lower lead levels; however, these differences were not statistically significant and this lack of significance could be due to the low prenatal lead levels in our population (median = 0.8, range = 0–13.1 μg/dL).

This study has several limitations. First, the relatively small sample size, further reduced in the stratified analyses (i.e., child sex and prenatal lead exposure), limited our statistical power. Second, we conducted multiple comparisons and cannot rule out the possibility that some associations were due to chance. However, given that conventional approaches for correcting for multiple comparisons have low efficiency and poor accuracy (Rothman et al. 2008), we were careful to point out patterns in our results rather than highlighting isolated findings. Third, although we were able to control for numerous potential confounders, residual confounding in the relationships between exposure to Mn and neurodevelopmental outcomes could exist. Finally, unlike most previous studies that were cross-sectional, we did not have measurements of Mn levels that were concurrent with the neurodevelopmental assessments.

Despite its limitations, the present study also has considerable strengths including its longitudinal design, use of comprehensive neurodevelopmental assessments at different ages, information on a wide variety of potential confounders, and use of a novel matrix for Mn measurements. We measured Mn levels in dentine of deciduous teeth, a biological matrix that, unlike enamel (Ericson et al. 2007), can be directly linked to the developmental timing of exposure (Smith 1998) and has been validated against other biomarkers of Mn exposure (Arora et al. 2012; Gunier et al. 2014). In contrast with other biological matrices that reflect short-term exposures (e.g., blood and urine reflect exposures of hours to days), dentine Mn measurements are useful in retrospectively discerning Mn levels in the developing fetus close to the time of birth and in estimating cumulative exposure over the perinatal period (Arora et al. 2012).

Overall, we found that higher Mn levels, as measured in deciduous teeth, were associated with poorer behavior in the CHAMACOS boys and girls, but better cognitive, visuospatial and verbal memory, and motor abilities in boys. These findings add to a growing literature addressing the potential developmental neurotoxicity of Mn exposure. However, additional research is needed to understand the inconsistencies in the neurodevelopmental findings across studies and the degree to which differences may be associated with Mn exposure pathways and biomarkers, child sex, and levels of other environmental toxicants such as lead.

Highlights.

  • Measured prenatal and postnatal Mn in dentine of deciduous teeth

  • Assessed neurodevelopment in children at ages 7, 9, and 10.5 years

  • Higher Mn associated with poorer behavioral outcomes

  • Higher Mn associated with better memory, cognitive, and motor abilities in boys

  • Not statistically significant but notable interaction between prenatal Mn and lead

Acknowledgments

We thank the CHAMACOS staff, students, community partners, and participants and families, as well as N. Holland and biorepository staff for their assistance in specimen management. We would also like to thank L. Pardo for her assistance with the literature review.

Funding sources: This work was funded by research grant numbers P01 ES009605 and R01 ES015572 from the National Institute for Environmental Health Sciences (NIEHS) and R 82670901, RD 83171001, and RD 83451301 from the U.S. Environmental Protection Agency (EPA). Mora is a scholar of the Ministry of Science, Technology and Telecommunications of Costa Rica (MICITT) and the Universidad Nacional, Costa Rica. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funders.

7. Appendices

Table A.1.

Distribution of Mn levels in teeth dentine (55Mn:43Ca AUC × 104), CHAMACOS Study, Salinas, California.

Biomarkers n Mean ± SD GM (GSD) Min Percentile
Max
25th 50th 75th
Prenatal Mn 248 0.50 ± 0.18 0.46 (1.48)   0.07 0.38 0.49 0.57 1.34
Postnatal Mn 244 0.19 ± 0.21 0.14 (2.47) 0.001 0.11 0.14 0.20 2.50

Abbreviations: AUC, area under the curve; SD, standard deviation; GM, geometric mean; GSD, geometric standard deviation.

Table A.2.

Means and standard deviations for behavioral, cognitive, memory, and motor outcomes in children at 7, 9, and 10.5 years.

Outcome na Mean ± SD
7-year assessment
Behavioral outcomes
CADS - Maternal Report (T-scores)
 ADHD Index 198 49.5 ± 7.7
 DSM-IV total scale 198 49.7 ± 8.0
  Inattentive subscale 198 48.6 ± 7.5
  Hyperactive/impulsive subscale 198 51.0 ± 7.8
BASC-2 - Maternal Report (T-scores)
 Internalizing problems 193 48.5 ± 9.7
 Externalizing problems 193 44.0 ± 8.2
  Attention problems 193 49.4 ± 10.6
  Hyperactivity 193 44.9 ± 8.1
CADS - Teacher Report (T-scores)
 ADHD Index 170 53.4 ± 11.6
 DSM-IV total scale 170 52.0 ± 9.9
  Inattentive subscale 173 48.3 ± 8.9
  Hyperactive/impulsive subscale 173 52.0 ± 10.1
BASC-2 - Teacher Report (T-scores)
 Internalizing problems 173 50.2 ± 11.9
 Externalizing problems 173 48.6 ± 9.2
  Attention problems 173 51.0 ± 7.8
  Hyperactivity 173 49.0 ± 10.0
Cognitive Outcomes
WISC-IV Full-Scale IQ (scaled scores) 175 104.1 ± 14.1
 Verbal Comprehension IQ 193 106.8 ± 16.7
 Perceptual Reasoning IQ 193 102.2 ± 16.8
 Working Memory IQ 176 93.4 ± 13.0
 Processing Speed IQ 176 109.0 ± 12.8
Motor Outcomes
WRAVMA Pegboard (scaled scores)
 Dominant hand 193 120.4 ± 17.0
 Non-dominant hand 193 122.7 ± 17.5
Finger Tap (raw scores)b
 Dominant hand 193 32.4 ± 6.2
 Non-dominant hand 193 28.6 ± 5.7
9-year assessment
Behavioral Outcomes
CADS - Maternal Report (T-scores)
 ADHD Index 243 51.1 ± 9.3
 DSM-IV total scale 242 51.5 ± 9.6
  Inattentive subscale 242 49.7 ± 9.0
  Hyperactive/impulsive subscale 242 53.5 ± 10.5
CPT-II (T-scores)
 Errors of omission 238 58.1 ± 16.8
 Errors of commission 238 49.7 ± 9.3
 ADHD Confidence index 238 52.2 ± 22.2
Memory Outcomes
NEPSY-II Memory for Designs (scaled scores)
 Immediate total 184 8.8 ± 3.3
 Delayed total 185 9.5 ± 3.3
Motor Outcomes
Luria-Nebraska Motor Scale (raw scores)b
 All items 227 54.8 ± 9.0
 5-item sum 227 41.6 ± 7.5
10.5-year assessment
Behavioral outcomes
BASC-2 - Maternal Report (T-scores)
 Internalizing problems 232 48.2 ± 8.7
 Externalizing problems 227 45.7 ± 7.3
  Attention problems 232 48.6 ± 10.6
  Hyperactivity 232 46.2 ± 7.5
BASC-2 - Self-report (sex-standardized T-scores)
 Attention problems 225 48.8 ± 9.1
 Hyperactivity 228 46.8 ± 9.0
Cognitive Outcomes
WISC-IV Full-Scale IQ (scaled scores) 231 90.8 ± 10.5
 Verbal Comprehension IQ 233 84.9 ± 11.5
 Perceptual Reasoning IQ 233 93.3 ± 14.3
 Working Memory IQ 233 97.0 ± 10.3
 Processing Speed IQ 233 99.2 ± 12.1
Memory Outcomes
CAVLT-2 (standardized scores)
 Immediate recall 233 98.9 ± 16.6
 Delayed recall 233 96.2 ± 15.9
 Immediate memory span 233 89.6 ± 15.2
 Level of learning 233 96.8 ± 14.6
Motor Outcomes
Luria-Nebraska Motor Scale (raw scores)b
 All items 233 48.3 ± 8.9
 5-item sum 233 35.1 ± 7.1

Abbreviations: SD, standard deviation; CADS, Conners’ ADHD/DSM-IV Scales; ADHD, Attention Deficit/Hyperactivity Disorder; BASC-2, Behavior Assessment System for Children 2nd edition; IQ, intellectual quotient; WRAVMA, Wide Range Assessment of Visual Motor Ability; CPT-II, continuous performance test 2nd edition; CAVLT-2, Children’s Auditory Verbal Learning Test 2nd edition.

a

Children who completed the 7-, 9-, or 10.5-year neurobehavioral assessment and had dentine Mn levels measured in shed incisors.

b

For statistical analysis, these scores were converted to z-scores for the CHAMACOS population.

Table A.3.

Generalized estimating equation models for behavioral, cognitive, and motor outcomes in children at 7, 9, and 10.5 years, per two-fold increase in prenatal and postnatal dentine Mn (55Mn:43Ca AUC × 104).

Outcomes Prenatal Mn
Postnatal Mn
n k β (95% CI) n k β (95% CI)
Behavioral outcomesa
CADS - Maternal report (T-scores)b, c
 ADHD Index 441 251 −0.2 (−1.7,1.3) 433 247 0.2 (−0.5,0.8)
 DSM-IV total scale 440 251 −0.1 (−1.8,1.6) 432 247 0.3 (−0.3,0.9)
  Inattentive subscale 440 251 −0.4 (−1.9,1.1) 432 247 0.2 (−0.4,0.7)
  Hyperactive/impulsive subscale 440 251   0.1 (−1.9,2.0) 432 247 0.4 (−0.2,1.0)
BASC-2 - Maternal report (T-scores)b, d
 Internalizing problems 425 245   0.8 (−0.9,2.5) 417 241   0.6 (0.0,1.2)
 Externalizing problems 420 244   0.1 (−1.3,1.6) 413 240 0.4 (−0.1,0.8)
  Attention problems 425 245 0.3 (−1.7,2.4) 417 241 0.0 (−0.7,0.8)
  Hyperactivity 425 245   0.2 (−1.2,1.6) 417 241 0.3 (−0.1,0.8)
Cognitive outcomes
WISC-IV Full-Scale IQ (Scaled scores)e, d 408 243   1.5 (−0.7,3.6) 400 239 0.7 (−0.3,1.6)
 Verbal Comprehension IQ 426 245   0.9 (−1.2,2.9) 418 241 0.6 (−0.1,1.4)
 Perceptual Reasoning IQ 426 245   2.5 (−1.0,6.1) 418 241 0.9 (−0.5,2.3)
 Working Memory IQ 409 243   1.0 (−1.1,3.1) 401 239 0.6 (−0.4,1.5)
 Processing Speed IQ 409 243   0.5 (−1.8,2.8) 401 239 −0.2 (−1.1,0.8)  
Motor outcomes
Luria-Nebraska Motor Scale (z-scores)e, f
 All items 460 239   0.1 (0.0,0.2) 452 235 0.0 (−0.1,0.0)
 5-item sum 460 239     0.2 (0.0,0.3)* 452 235 0.0 (−0.1,0.0)

Abbreviations: n, number of observations; k, number of children; CI, confidence interval; CADS, Conners’ ADHD/DSM-IV Scales; ADHD, Attention Deficit/Hyperactivity Disorder; BASC-2, Behavior Assessment System for Children 2nd edition; WISC-IV, Wechsler Intelligence Scale for Children 4th edition; IQ, intellectual quotient.

a

Higher scores indicate poorer performance or more symptomatic behavior.

b

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex and age at maternal interview; language of maternal interview; HOME z-score, household income, and number of children in the home at time of assessment.

c

Outcomes measured at 7 and 9 years.

d

Outcomes measured at 7 and 10.5 years.

e

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home at time of assessment, and psychometrician at time of assessment.

f

Outcomes measured at 9 and 10.5 years.

*

pLinear <0.10

**

pLinear <0.05.

Table A.4.

Adjusted linear models for behavioral outcomes in children at 7, 9, and 10.5 years, per twofold increase in prenatal dentine Mn (55Mn:43Ca AUC × 104) stratified by prenatal lead exposure (maternal blood lead levels during pregnancy < 0.8 vs. ≥ 0.8 μg/dL).

Outcomesa Lower lead exposure
Higher lead exposure
pINT
n β (95% CI) n β (95% CI)
7-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 85 −1.0 (−4.0,2.0)   85 −0.5 (−3.2,2.3)   0.96
 DSM-IV total scale 85 −0.9 (−3.8,1.9)   85 −1.1 (−3.8,1.5)   0.95
  Inattentive subscale 85 −2.5 (−4.9, −0.2)**   85 −0.9 (−3.4,1.6)   0.47
  Hyperactive/impulsive subscale 85 0.7 (−2.6,3.9) 85 −1.3 (−4.0,1.4)   0.39
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 83   3.9 (−0.5,8.4)* 82 −0.7 (−3.6,2.1)   0.08
 Externalizing problems 83 1.1 (−1.8,4.0) 82 0.5 (−2.5,3.4) 0.58
  Attention problems 83 1.8 (−1.3,5.0) 82 0.4 (−2.5,3.2) 0.57
  Hyperactivity 83 −2.3 (−6.0,1.4)   82 0.4 (−4.3,5.2) 0.47
CADS - Teacher report (T-scores)c
 ADHD Index 73 −4.6 (−10.7,1.6)     71 1.1 (−2.5,4.7) 0.12
 DSM-IV total scale 73 −3.2 (−8.9,2.5)   71 1.8 (−1.2,4.8) 0.09
  Inattentive subscale 74 −2.4 (−7.0,2.1)   73       2.7 (0.4,5.0)** 0.03
  Hyperactive/impulsive subscale 74 −3.4 (−9.3,2.5)   73 −0.2 (−3.5,3.2)   0.33
BASC-2 - Teacher report (T-scores)c
 Internalizing problems 74 −5.5 (−9.6, −1.3)**   73 −0.7 (−6.7,5.3)   0.46
 Externalizing problems 74 −1.4 (−6.2,3.4)   73 1.5 (−1.3,4.3) 0.25
  Attention problems 74 −2.3 (−7.8,3.2)   73 0.3 (−2.7,3.3) 0.19
  Hyperactivity 74 −2.5 (−6.3,1.4)   73 0.3 (−1.9,2.5) 0.29
9-year assessment
CADS - Maternal report (T-scores)b
 ADHD Index 83 −0.8 (−6.6,4.9)   83 −0.1 (−2.7,2.6)   0.95
 DSM-IV total scale 83 1.9 (−4.7,8.4) 82 0.3 (−2.4,3.0) 0.62
  Inattentive subscale 83 −0.1 (−5.9,5.6)   82 −1.0 (−3.5,1.5)   0.92
  Hyperactive/impulsive subscale 83 3.8 (−3.8,11.5)   82 2.0 (−1.2,5.2) 0.47
CPT-II (T-scores)d
 Errors of omission 80 −8.2 (−16.8,0.5)*   81 −6.4 (−14.5,1.7)     0.72
 Errors of commission 80 −2.9 (−7.8,2.0)   81 −1.4 (−5.6,2.8)   0.68
 ADHD Confidence index 80 −13.9 (−23.4, −4.4)**       81 −7.1 (−16.7,2.5)     0.44
10.5-year assessment
BASC-2 - Maternal report (T-scores)b
 Internalizing problems 79       5.1 (1.9,8.3)** 79 −0.2 (−2.7,2.3)   0.01
 Externalizing problems 77 1.7 (−2.1,5.4) 78 1.8 (−0.5,4.1) 0.87
  Attention problems 79 −2.2 (−7.8,3.4)   79 0.2 (−3.5,3.9) 0.70
  Hyperactivity 79 2.7 (−0.9,6.3) 79 0.7 (−1.7,3.1) 0.45
BASC-2 - Self-report (T-scores)d
 Attention problems 75 2.0 (−2.8,6.8) 77 −0.7 (−4.2,2.7)   0.83
 Hyperactivity 77 2.0 (−2.1,6.2) 78 −2.2 (−7.5,3.1)   0.42

Abbreviations: AUC, area under the curve; CADS, Conners’ ADHD/DSM-IV Scales; ADHD, Attention Deficit/Hyperactivity Disorder; BASC-2, Behavior Assessment System for Children 2nd edition; CPT-II, Continuous Performance Test 2nd edition.

a

Higher scores indicate poorer performance or more symptomatic behavior.

b

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex and age at maternal interview; language of maternal interview; HOME z-score, household income, and number of children in the home at time of assessment.

c

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex and age at interview; HOME z-score, household income, and number of children in the home at time of assessment.

d

Adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05.

Table A.5.

Adjusted linear models for cognition, memory, and motor outcomes in children at 7, 9, and 10.5 years per two-fold increase in prenatal dentine Mn (55Mn:43Ca AUC × 104) stratified by prenatal lead exposure (maternal blood lead levels during pregnancy < 0.8 vs. ≥ 0.8 μg/dL).

Outcomes Lower lead exposure
Higher lead exposure
pINT
n β (95% CI) n β (95% CI)
Cognition
7-year assessment
WISC-IV Full-Scale IQ (scaled scores) 80 3.7 (−2.8,10.3)   78   −3.5 (−7.2,0.2)* 0.08
 Verbal Comprehension IQ 83 1.3 (−4.3,7.0) 82 −2.7 (−6.8,1.3) 0.29
 Perceptual Reasoning IQ 83 3.0 (−5.0,11.0)   82 −3.2 (−9.2,2.8) 0.21
  Working Memory IQ 81 0.5 (−6.1,7.2) 78 −1.4 (−5.1,2.4) 0.54
  Processing Speed IQ 81   7.5 (1.8,13.2)** 78 −1.4 (−5.5,2.8) 0.10
10.5-year assessment
WISC-IV Full-Scale IQ (scaled scores) 78 1.5 (−4.1,7.1) 79   −3.7 (−7.7,0.2)* 0.21
 Verbal Comprehension IQ 79 −3.5 (−7.9,0.9)   80 −4.1 (−8.0, −0.3)** 0.97
 Perceptual Reasoning IQ 79 3.3 (−4.6,11.1)   80 −3.3 (−9.1,2.5) 0.20
  Working Memory IQ 79 3.9 (−1.1,8.9) 80 −0.9 (−5.3,3.6) 0.21
  Processing Speed IQ 79 2.9 (−2.5,8.3) 80 −1.0 (−5.4,3.4) 0.52
Memory
9-year assessment
NEPSY-II Memory for Designs (scaled scores)
 Immediate Total 79 1.2 (−0.8,3.2) 79 −0.1 (−1.7,1.4) 0.40
 Delayed Total 79   1.9 (−0.2,4.0)* 80   −1.2 (−2.4,0.0)* 0.04
10.5-year assessment
CAVLT-2 (standardized scores)
 Immediate recall 79 −4.5 (−13.6,4.7)     80 4.1 (−2.7,11.0) 0.11
 Delayed recall 79 1.3 (−8.0,10.5)   80 4.3 (−2.1,10.6) 0.61
  Immediate memory span 79 2.7 (−4.1,9.4) 80 −4.3 (−10.9,2.2)   0.31
  Level of learning 79 2.8 (−5.2,10.8)   80   2.3 (−3.4,8.1) 0.84
Motor function
7-year assessment
WRAVMA Pegboard (scaled scores)
 Dominant hand 83 5.3 (−2.6,13.3)   82 −0.3 (−5.8,5.1) 0.19
 Non-dominant hand 83 4.8 (−3.2,12.7)   82   0.4 (−6.2,7.0) 0.45
Finger Tap (z-scores)
 Dominant hand 83     0.4 (0.0,0.9)* 82 −0.1 (−0.5,0.2) 0.25
 Non-dominant hand 83 0.2 (−0.3,0.7) 82 −0.1 (−0.5,0.2) 0.70
9-year assessment
Luria-Nebraska Motor Scale (z-scores)
 All items 80 0.2 (−0.2,0.7) 78 −0.2 (−0.6,0.2) 0.20
 5-item sum 80 0.3 (−0.2,0.7) 78 −0.2 (−0.7,0.3) 0.21
10.5-year assessment
Luria-Nebraska Motor Scale (z-scores)
 All items 79 0.2 (−0.2,0.5) 80   0.1 (−0.2,0.3) 0.93
 5-item sum 79 0.1 (−0.4,0.6) 80   0.0 (−0.4,0.4) 0.92

Abbreviations: AUC, area under the curve; CI, confidence interval; WISC-IV, Wechsler Intelligence Scale for Children 4th edition; IQ, intellectual quotient; CAVLT-2, Children’s Auditory Verbal Learning Test 2nd edition; WRAVMA, Wide Range Assessment of Visual Motor Ability.

Models adjusted for maternal education, intelligence (PPVT score), years in the US, and depression at time of assessment; child’s sex, age at assessment, and language of assessment; HOME z-score, household income, number of children in the home, and psychometrician at time of assessment (9-year and 10.5-year assessments).

*

pLinear <0.10

**

pLinear <0.05.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

1

Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; AUC, Area Under the Curve; BASC-2, Behavior Assessment Scale for Children, 2nd edition; CADS, Conners’ ADHD/DSM-IV Scales, Parent and Teacher versions; CAVLT-2, Children’s Auditory Verbal Learning Test, 2nd edition; CES-D, Center for Epidemiologic Studies Depression Scale; CHAM1, Initial CHAMACOS cohort (recruited 1999–2000 during pregnancy); CHAM2, Second CHAMACOS cohort (recruited 2009–2011 at child age 9); CHAMACOS, Center for the Health Assessment of Mothers and Children of Salinas; CI, Confidence Interval; CPT-II, Conners’ Continuous Performance Test II, Version 5; DAP, Dialkyl phosphate; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; GEE, Generalized Estimating Equations; GM, Geometric Mean; HOME, Home Observation for Measurement of the Environment; IQ, Intelligence Quotient; LOD, Limit of Detection; Mn, Manganese; NEPSY-II, A Developmental NEuroPSYchological Assessment, 2nd edition; OP, Organophosphate; PBDE, Polybrominated Diphenyl Ether; PPVT, Peabody Picture Vocabulary Test; TVIP, Test de Vocabulario en Imágenes Peabody; SD, Standard Deviation; SE, Standard Error; WISC-IV, Wechsler Intelligence Scale for Children, 4th edition; WRAVMA, Wide Range Assessment of Visual Motor Ability.

Conflict of interest statement

One of the authors (AB) has served as a consultant on cases unrelated to the issues covered in this paper and has participated as a member of the board for The Organic Center, a non-profit organization that provides information for scientific research about organic food and farming. The other authors declare they have no actual or potential competing financial interests.

References

  1. Adams W, Sheslow D. Wide Range Assessment of Visual Motor Abilities (WRAVMA) Wilmington, DE: Wide Range, Inc; 1995. [Google Scholar]
  2. Arora M, Hare D, Austin C, Smith DR, Doble P. Spatial distribution of manganese in enamel and coronal dentine of human primary teeth. Sci Total Environ. 2011;409(7):1315–1319. doi: 10.1016/j.scitotenv.2010.12.018. [DOI] [PubMed] [Google Scholar]
  3. Arora M, Bradman A, Austin C, Vedar M, Holland N, Eskenazi B, et al. Determining fetal manganese exposure from mantle dentine of deciduous teeth. Environ Sci Technol. 2012;46(9):5118–5125. doi: 10.1021/es203569f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aschner M. Manganese: brain transport and emerging research needs. Environ Health Perspect. 2000;108(Suppl 3):429–432. doi: 10.1289/ehp.00108s3429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aschner M, Dorman DC. Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev. 2006;25(3):147–154. doi: 10.2165/00139709-200625030-00002. [DOI] [PubMed] [Google Scholar]
  6. ATDSR. Toxicological Profile for Manganese. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2012. [PubMed] [Google Scholar]
  7. Battistone GC, Feldman MH, Reba RC. The manganese content of human enamel and dentine. Arch Oral Biol. 1967;12:1115–1122. doi: 10.1016/0003-9969(67)90059-3. [DOI] [PubMed] [Google Scholar]
  8. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect. 2007;115(1):122–127. doi: 10.1289/ehp.9504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bouchard MF, Sauve S, Barbeau B, Legrand M, Brodeur ME, Bouffard T, et al. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect. 2011a;119(1):138–143. doi: 10.1289/ehp.1002321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect. 2011b;119(8):1189–1195. doi: 10.1289/ehp.1003185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bradman A, Eskenazi B, Barr DB, Bravo R, Castorina R, Chevrier J, et al. Organophosphate urinary metabolite levels during pregnancy and after delivery in women living in an agricultural community. Environ Health Perspect. 2005;113(12):1802–1807. doi: 10.1289/ehp.7894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Caldwell B, Bradley R. Home observation for measurement of the environment. Little Rock, AR: University of Arkansas; 1984. [Google Scholar]
  13. CDPR. California Pesticide Use Reporting Data. Sacramento, CA: California Department of Pesticide Regulation; 2001. [Google Scholar]
  14. CDPR. California Pesticide Use Reporting Data. Sacramento, CA: California Department of Pesticide Regulation; 2014. [Google Scholar]
  15. Chung SE, Cheong HK, Ha EH, Kim BN, Ha M, Kim Y, et al. Maternal blood manganese and early neurodevelopment: The Mothers and Children’s Environmental Health (MOCEH) Study. Environ Health Perspect. 2015 doi: 10.1289/ehp.1307865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Claus Henn B, Ettinger AS, Schwartz J, Tellez-Rojo MM, Lamadrid-Figueroa H, Hernandez-Avila M, et al. Early postnatal blood manganese levels and children’s neurodevelopment. Epidemiology. 2010;21(4):433–439. doi: 10.1097/ede.0b013e3181df8e52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Claus Henn B, Schnaas L, Ettinger AS, Schwartz J, Lamadrid-Figueroa H, Hernandez-Avila M, et al. Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect. 2012;120(1):126–131. doi: 10.1289/ehp.1003300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Conners CK. Conner’s Rating Scales–Revised (CSR-R) Technical Manual (includes auxiliary scales: CADS-P and CADS-T) North Tonawanda, NY: Multi-Health Systems Inc; 2001. [Google Scholar]
  19. Conners CK. Conners’ Continuous Performance Test II (CPT-II): Computer Program for Windows Technical Guide and Software Manual. Toronto, ON, Canada: Multi-Health Systems Inc; 2002. [Google Scholar]
  20. Dorman DC, Brenneman KA, McElveen AM, Lynch SE, Roberts KC, Wong BA. Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain. J Toxicol Environ Health A. 2002;65(20):1493–1511. doi: 10.1080/00984100290071630. [DOI] [PubMed] [Google Scholar]
  21. Dorman DC, McManus BE, Marshall MW, James RA, Struve MF. Old age and gender influence the pharmacokinetics of inhaled manganese sulfate and manganese phosphate in rats. Toxicol Appl Pharmacol. 2004;197(2):113–124. doi: 10.1016/j.taap.2004.02.010. [DOI] [PubMed] [Google Scholar]
  22. Dunn L, Dunn L. Peabody Picture Vocabulary Test, Revised. Circle Pines, MN: American Guidance Service; 1981. [Google Scholar]
  23. Eastman RR, Jursa TP, Benedetti C, Lucchini RG, Smith DR. Hair as a biomarker of environmental manganese exposure. Environ Sci Technol. 2013;47(3):1629–1637. doi: 10.1021/es3035297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114(8):1172–1178. doi: 10.1289/ehp.9030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ericson JE, Crinella FM, Clarke-Stewart KA, Allhusen VD, Chan T, Robertson RT. Prenatal manganese levels linked to childhood behavioral disinhibition. Neurotoxicol Teratol. 2007;29(2):181–187. doi: 10.1016/j.ntt.2006.09.020. [DOI] [PubMed] [Google Scholar]
  26. Eskenazi B, Harley K, Bradman A, Weltzien E, Jewell NP, Barr DB, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect. 2004;112(10):1116–1124. doi: 10.1289/ehp.6789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Eskenazi B, Marks AR, Bradman A, Fenster L, Johnson C, Barr DB, et al. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics. 2006;118(1):233–241. doi: 10.1542/peds.2005-3117. [DOI] [PubMed] [Google Scholar]
  28. Eskenazi B, Chevrier J, Rauch SA, Kogut K, Harley KG, Johnson C, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121(2):257–262. doi: 10.1289/ehp.1205597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. FAO. Mancozeb. Rome, Italy: Food and Agriculture Organization of the United Nations; 1980. [Google Scholar]
  30. Golden CJ, Hammeke T, Purish A. Manual for the Luria Nebraska neuropsychological battery. Los Angeles, CA: Western Psychological Services; 1980. [Google Scholar]
  31. Gunier RB, Bradman A, Jerrett M, Smith DR, Harley KG, Austin C, et al. Determinants of manganese in prenatal dentin of shed teeth from CHAMACOS children living in an agricultural community. Environ Sci Technol. 2013;47(19):11249–11257. doi: 10.1021/es4018688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gunier RB, Mora AM, Smith D, Arora M, Austin C, Eskenazi B, et al. Biomarkers of manganese exposure in pregnant women and children living in an agricultural community in California. Environ Sci Technol. 2014;48:14695–14702. doi: 10.1021/es503866a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gwiazda RH, Lee D, Sheridan J, Smith DR. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology. 2002;23(1):69–76. doi: 10.1016/s0161-813x(02)00002-5. [DOI] [PubMed] [Google Scholar]
  34. Haynes EN, Heckel P, Ryan P, Roda S, Leung YK, Sebastian K, et al. Environmental manganese exposure in residents living near a ferromanganese refinery in Southeast Ohio: a pilot study. Neurotoxicology. 2010;31(5):468–474. doi: 10.1016/j.neuro.2009.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. He P, Liu DH, Zhang GQ. Effects of high-level-manganese sewage irrigation on children’s neurobehavior. Zhonghua Yu Fang Yi Xue Za Zhi. 1994;28(4):216–218. [PubMed] [Google Scholar]
  36. Hernandez-Bonilla D, Schilmann A, Montes S, Rodriguez-Agudelo Y, Rodriguez-Dozal S, Solis-Vivanco R, et al. Environmental exposure to manganese and motor function of children in Mexico. Neurotoxicology. 2011;32(5):615–621. doi: 10.1016/j.neuro.2011.07.010. [DOI] [PubMed] [Google Scholar]
  37. Khan K, Wasserman GA, Liu X, Ahmed E, Parvez F, Slavkovich V, et al. Manganese exposure from drinking water and children’s academic achievement. Neurotoxicology. 2012;33(1):91–97. doi: 10.1016/j.neuro.2011.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kim Y, Kim BN, Hong YC, Shin MS, Yoo HJ, Kim JW, et al. Co-exposure to environmental lead and manganese affects the intelligence of school-aged children. Neurotoxicology. 2009;30(4):564–571. doi: 10.1016/j.neuro.2009.03.012. [DOI] [PubMed] [Google Scholar]
  39. Kondakis XG, Makris N, Leotsinidis M, Prinou M, Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch Environ Health. 1989;44(3):175–178. doi: 10.1080/00039896.1989.9935883. [DOI] [PubMed] [Google Scholar]
  40. Korkman M, Kirk U, Kemp SL. NEPSY-II: A Developmental Neuropsychologial Assessment. San Antonio, TX: The Psychological Corporation; 2007. [Google Scholar]
  41. Lappalainen R, Knuuttila M. Atomic absorption spectrometric evidence of relationships between some cationic elements in human dentine. Arch Oral Biol. 1982;27:827–830. doi: 10.1016/0003-9969(82)90037-1. [DOI] [PubMed] [Google Scholar]
  42. Leavens TL, Rao D, Andersen ME, Dorman DC. Evaluating transport of manganese from olfactory mucosa to striatum by pharmacokinetic modeling. Toxicol Sci. 2007;97(2):265–278. doi: 10.1093/toxsci/kfm061. [DOI] [PubMed] [Google Scholar]
  43. Lin CC, Chen YC, Su FC, Lin CM, Liao HF, Hwang YH, et al. In utero exposure to environmental lead and manganese and neurodevelopment at 2 years of age. Environ Res. 2013;123:52–57. doi: 10.1016/j.envres.2013.03.003. [DOI] [PubMed] [Google Scholar]
  44. Ljung K, Vahter M. Time to re-evaluate the guideline value for manganese in drinking water? Environ Health Perspect. 2007;115(11):1533–1538. doi: 10.1289/ehp.10316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lucchini RG, Guazzetti S, Zoni S, Donna F, Peter S, Zacco A, et al. Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. Neurotoxicology. 2012;33(4):687–696. doi: 10.1016/j.neuro.2012.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Madison JL, Wegrzynowicz M, Aschner M, Bowman AB. Gender and manganese exposure interactions on mouse striatal neuron morphology. Neurotoxicology. 2011;32(6):896–906. doi: 10.1016/j.neuro.2011.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Marks AR, Harley K, Bradman A, Kogut K, Barr DB, Johnson C, et al. Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ Health Perspect. 2010;118(12):1768–1774. doi: 10.1289/ehp.1002056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Menezes-Filho JA, Bouchard M, Sarcinelli Pde N, Moreira JC. Manganese exposure and the neuropsychological effect on children and adolescents: A review. Rev Panam Salud Publica. 2009a;26:541–548. doi: 10.1590/s1020-49892009001200010. [DOI] [PubMed] [Google Scholar]
  49. Menezes-Filho JA, Paes CR, Pontes AM, Moreira JC, Sarcinelli PN, Mergler D. High levels of hair manganese in children living in the vicinity of a ferro-manganese alloy production plant. Neurotoxicology. 2009b;30:1207–1213. doi: 10.1016/j.neuro.2009.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Menezes-Filho JA, Novaes Cde O, Moreira JC, Sarcinelli PN, Mergler D. Elevated manganese and cognitive performance in school-aged children and their mothers. Environ Res. 2011;111(1):156–163. doi: 10.1016/j.envres.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Menezes-Filho JA, de Carvalho-Vivas CF, Viana GF, Ferreira JR, Nunes LS, Mergler D, et al. Elevated manganese exposure and school-aged children’s behavior: A gender-stratified analysis. Neurotoxicology. 2014;45:293–300. doi: 10.1016/j.neuro.2013.09.006. [DOI] [PubMed] [Google Scholar]
  52. Mergler D, Baldwin M. Early manifestations of manganese neurotoxicity in humans: An update. Environ Res. 1997;73:92–100. doi: 10.1006/enrs.1997.3710. [DOI] [PubMed] [Google Scholar]
  53. Mergler D, Baldwin M, Belanger S, Larribe F, Beuter A, Bowler R, et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999;20(2–3):327–342. [PubMed] [Google Scholar]
  54. Mora AM, van Wendel de Joode B, Mergler D, Cordoba L, Cano C, Quesada R, et al. Blood and Hair Manganese Concentrations in Pregnant Women from the Infants’ Environmental Health Study (ISA) in Costa Rica. Environ Sci Technol. 2014;48(6):3467–3476. doi: 10.1021/es404279r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Papavasiliou PS, Miller ST, Cotzias GC. Role of liver in regulating distribution and excretion of manganese. Am J Physiol. 1966;211(1):211–216. doi: 10.1152/ajplegacy.1966.211.1.211. [DOI] [PubMed] [Google Scholar]
  56. Phillips DL, Pirkle JL, Burse VW, Bernert JT, Jr, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol. 1989;18(4):495–500. doi: 10.1007/BF01055015. [DOI] [PubMed] [Google Scholar]
  57. Radloff L. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Appl Psychological Meas. 1977;1:385–401. [Google Scholar]
  58. Reynolds CR, Kamphaus RW. BASC-2: Behaviour Assessment System for Children, Second Edition Manual Circle Pines. MN: AGS Publishing; 2004. [Google Scholar]
  59. Rink SM, Ardoino G, Queirolo EI, Cicariello D, Manay N, Kordas K. Associations between hair manganese levels and cognitive, language, and motor development in preschool children from Montevideo, Uruguay. Arch Environ Occup Health. 2014;69(1):46–54. doi: 10.1080/19338244.2012.725229. [DOI] [PubMed] [Google Scholar]
  60. Riojas-Rodriguez H, Solis-Vivanco R, Schilmann A, Montes S, Rodriguez S, Rios C, et al. Intellectual function in Mexican children living in a mining area and environmentally exposed to manganese. Environ Health Perspect. 2010;118(10):1465–1470. doi: 10.1289/ehp.0901229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Roels HA, Bowler RM, Kim Y, Claus Henn B, Mergler D, Hoet P, et al. Manganese exposure and cognitive deficits: A growing concern for manganese neurotoxicity. Neurotoxicology. 2012;33:872–880. doi: 10.1016/j.neuro.2012.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Roth JA. Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biol Res. 2006;39(1):45–57. doi: 10.4067/s0716-97602006000100006. [DOI] [PubMed] [Google Scholar]
  63. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd. Philadelphia, PA: Lippincott Williams and Wilkins; 2008. [Google Scholar]
  64. Sabel N, Johansson C, Kuhnisch J, Robertson A, Steiniger F, Noren JG, et al. Neonatal lines in the enamel of primary teeth–a morphological and scanning electron microscopic investigation. Arch Oral Biol. 2008;53:954–963. doi: 10.1016/j.archoralbio.2008.05.003. [DOI] [PubMed] [Google Scholar]
  65. Sjodin A, Jones RS, Lapeza CR, Focant JF, McGahee EE, 3rd, Patterson DG., Jr Semiautomated high-throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem. 2004;76(7):1921–1927. doi: 10.1021/ac030381+. [DOI] [PubMed] [Google Scholar]
  66. Smith CE. Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med. 1998;9:128–161. doi: 10.1177/10454411980090020101. [DOI] [PubMed] [Google Scholar]
  67. Smith D, Gwiazda R, Bowler R, Roels H, Park R, Taicher C, et al. Biomarkers of Mn exposure in humans. Am J Ind Med. 2007;50(11):801–811. doi: 10.1002/ajim.20506. [DOI] [PubMed] [Google Scholar]
  68. Takser L, Mergler D, Hellier G, Sahuquillo J, Huel G. Manganese, monoamine metabolite levels at birth, and child psychomotor development. Neurotoxicology. 2003;24(4–5):667–674. doi: 10.1016/S0161-813X(03)00058-5. [DOI] [PubMed] [Google Scholar]
  69. Talley J. Children’s Auditory Verbal Learning Test-Second edition (CAVLT-2) Lutz, FL: Psychological Assessment Resources; 1997. [Google Scholar]
  70. Torres-Agustin R, Rodriguez-Agudelo Y, Schilmann A, Solis-Vivanco R, Montes S, Riojas-Rodriguez H, et al. Effect of environmental manganese exposure on verbal learning and memory in Mexican children. Environ Res. 2013;121:39–44. doi: 10.1016/j.envres.2012.10.007. [DOI] [PubMed] [Google Scholar]
  71. Vitarella D, Wong BA, Moss OR, Dorman DC. Pharmacokinetics of inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14-day) exposure. Toxicol Appl Pharmacol. 2000;163(3):279–285. doi: 10.1006/taap.1999.8874. [DOI] [PubMed] [Google Scholar]
  72. Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P, et al. Water manganese exposure and children’s intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2006;114(1):124–129. doi: 10.1289/ehp.8030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Wechsler D. Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV) Administration and Scoring Manual. San Antonio, TX: Harcourt Assessment Incorporated; 2003. [Google Scholar]
  74. Woodcock RW, Johnson MB. Woodcock-Johnson Psycho-educational Battery-Revised. Itasca, IL: Riverside; 1990. [Google Scholar]
  75. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006;27(2):210–216. doi: 10.1016/j.neuro.2005.10.001. [DOI] [PubMed] [Google Scholar]
  76. Yoon M, Nong A, Clewell HJ, 3rd, Taylor MD, Dorman DC, Andersen ME. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model. Toxicol Sci. 2009;112(1):44–58. doi: 10.1093/toxsci/kfp198. [DOI] [PubMed] [Google Scholar]
  77. Zayed J, Vyskocil A, Kennedy G. Environmental contamination and human exposure to manganese–contribution of methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline. Int Arch Occup Environ Health. 1999;72(1):7–13. doi: 10.1007/s004200050327. [DOI] [PubMed] [Google Scholar]
  78. Zhang G, Liu D, He P. Effects of manganese on learning abilities in school children. Zhonghua Yu Fang Yi Xue Za Zhi. 1995;29(3):156–158. [PubMed] [Google Scholar]

RESOURCES